Ytyt的个人主页 - 老虎社区

Ytyt

暂无个人介绍

IP属地：未知

279关注

8粉丝

0主题

0勋章

2021-12-16

Pls like

抱歉，原内容已删除

2021-11-18

Pls like

抱歉，原内容已删除

2021-11-17

Pls like

抱歉，原内容已删除

2021-09-25

Pls like

5 Top Consumer Stocks To Watch Ahead Of October 2021<blockquote>2021年10月之前值得关注的5只顶级消费股</blockquote>

2021-12-28

Pls like

Novavax shares dropped another 4% in premarket trading<blockquote>Novavax股价在盘前交易中又下跌4%</blockquote>

2021-12-22

Pls like

抱歉，原内容已删除

2021-12-04

Pls like

抱歉，原内容已删除

2021-12-26

Pls like

抱歉，原内容已删除

2021-12-25

Pls like

抱歉，原内容已删除

2021-12-24

Pls like

抱歉，原内容已删除

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"4094269572113460","uuid":"4094269572113460","gmtCreate":1631257775982,"gmtModify":1631257775982,"name":"Ytyt","pinyin":"ytyt","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":8,"headSize":279,"tweetSize":69,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.01.02","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":692999360,"gmtCreate":1640821878867,"gmtModify":1640821879094,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094269572113460","authorIdStr":"4094269572113460"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/692999360","repostId":"2195466435","repostType":4,"isVote":1,"tweetType":1,"viewCount":4897,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696664524,"gmtCreate":1640685161869,"gmtModify":1640685637729,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094269572113460","authorIdStr":"4094269572113460"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/696664524","repostId":"1138246031","repostType":4,"repost":{"id":"1138246031","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640683578,"share":"https://www.laohu8.com/m/news/1138246031?lang=zh_CN&edition=full","pubTime":"2021-12-28 17:26","market":"us","language":"en","title":"Novavax shares dropped another 4% in premarket trading<blockquote>Novavax股价在盘前交易中又下跌4%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1138246031","media":"Tiger Newspress","summary":"Novavax shares dropped another 4% in premarket trading.The stock plunged nearly 11% yesterday.\n\nWhy ","content":"<p>Novavax shares dropped another 4% in premarket trading.The stock plunged&nbsp;nearly 11% yesterday.</p><p><blockquote>Novavax股价在盘前交易中又下跌4%。该股昨日暴跌近11%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/04a11fff9a31214bbcf7595183a5d305\" tg-width=\"843\" tg-height=\"618\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> <b>Why Novavax Stock Is Sinking</b></p><p><blockquote><b>为什么Novavax股价下跌</b></blockquote></p><p> The company didn't announce any new developments. So what's behind the big decline?</p><p><blockquote>该公司没有宣布任何新的进展。那么大跌的背后是什么呢？</blockquote></p><p> Other&nbsp;vaccine stocks&nbsp;aren't falling nearly as much. Some were even up a little. That rules out the likelihood that declining concerns about the omicron variant played a major factor behind Novavax's drop.</p><p><blockquote>其他疫苗股的跌幅也没有那么大。有些甚至涨了一点。这排除了对奥密克戎变种的担忧下降是Novavax股价下跌的主要因素的可能性。</blockquote></p><p> Instead, investors are probably growing more anxious about Novavax's planned filing for U.S. Emergency Use Authorization (EUA) of it COVID-19 vaccine NVX-CoV2373. Some investors could also be worried about the quality of Novavax's submission to the Food and Drug Administration (FDA) even if it doesn't experience another delay with the filing.</p><p><blockquote>相反，投资者可能对Novavax计划向美国申请其COVID-19疫苗NVX-CoV2373紧急使用授权(EUA)越来越焦虑。一些投资者还可能担心Novavax向美国食品和药物管理局(FDA)提交的文件的质量，即使它的提交没有再次出现延迟。</blockquote></p><p> CEO Stanley Erck's interview with Yahoo! Finance Live last Thursday likely didn't help reassure investors. When asked about when the FDA filing would be done, Erck replied, \"It's probably going to be next week, but I'm sticking with the claim that we'll be doing this by the end of this year.\"</p><p><blockquote>首席执行官斯坦利·埃尔克接受雅虎采访！上周四的财经直播可能无助于安抚投资者。当被问及何时完成FDA备案时，Erck回答说：“可能是下周，但我坚持认为我们将在今年年底前完成这项工作。”</blockquote></p><p> <b>So what</b></p><p><blockquote><b>那又怎样</b></blockquote></p><p> Yet another delay in a U.S. filing for NVX-CoV2373 wouldn't be catastrophic for Novavax as long as the company completes the submission soon in the new year. However, management's credibility would definitely take another big blow.</p><p><blockquote>只要Novavax在新年尽快完成提交，NVX-CoV2373在美国的申请再次延迟对该公司来说不会是灾难性的。然而，管理层的信誉肯定会再次受到重大打击。</blockquote></p><p> But it's premature at this point to speculate that Novavax won't complete the U.S. EUA filing this week. It's also useless to fret about the quality of the company's FDA package. Novavax recently won European Union authorization for NVX-CoV2373. That shows that the vaccine maker can successfully meet regulators' manufacturing-quality hurdles.</p><p><blockquote>但目前推测Novavax本周不会完成美国EUA备案还为时过早。担心该公司FDA包装的质量也是没有用的。Novavax最近获得了NVX-CoV2373的欧盟授权。这表明疫苗制造商能够成功满足监管机构的生产质量障碍。</blockquote></p><p> <b>Now what</b></p><p><blockquote><b>现在怎么办</b></blockquote></p><p> Investors don't like waiting, but that's exactly what they'll have to do for now with Novavax. The company could complete its EUA filing any day now. It could also pick up new authorizations in other countries where it awaits regulatory decisions.</p><p><blockquote>投资者不喜欢等待，但这正是他们目前对Novavax必须做的事情。该公司现在可以随时完成EUA备案。它还可能在等待监管决定的其他国家获得新的授权。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax shares dropped another 4% in premarket trading<blockquote>Novavax股价在盘前交易中又下跌4%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax shares dropped another 4% in premarket trading<blockquote>Novavax股价在盘前交易中又下跌4%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-28 17:26</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Novavax shares dropped another 4% in premarket trading.The stock plunged&nbsp;nearly 11% yesterday.</p><p><blockquote>Novavax股价在盘前交易中又下跌4%。该股昨日暴跌近11%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/04a11fff9a31214bbcf7595183a5d305\" tg-width=\"843\" tg-height=\"618\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> <b>Why Novavax Stock Is Sinking</b></p><p><blockquote><b>为什么Novavax股价下跌</b></blockquote></p><p> The company didn't announce any new developments. So what's behind the big decline?</p><p><blockquote>该公司没有宣布任何新的进展。那么大跌的背后是什么呢？</blockquote></p><p> Other&nbsp;vaccine stocks&nbsp;aren't falling nearly as much. Some were even up a little. That rules out the likelihood that declining concerns about the omicron variant played a major factor behind Novavax's drop.</p><p><blockquote>其他疫苗股的跌幅也没有那么大。有些甚至涨了一点。这排除了对奥密克戎变种的担忧下降是Novavax股价下跌的主要因素的可能性。</blockquote></p><p> Instead, investors are probably growing more anxious about Novavax's planned filing for U.S. Emergency Use Authorization (EUA) of it COVID-19 vaccine NVX-CoV2373. Some investors could also be worried about the quality of Novavax's submission to the Food and Drug Administration (FDA) even if it doesn't experience another delay with the filing.</p><p><blockquote>相反，投资者可能对Novavax计划向美国申请其COVID-19疫苗NVX-CoV2373紧急使用授权(EUA)越来越焦虑。一些投资者还可能担心Novavax向美国食品和药物管理局(FDA)提交的文件的质量，即使它的提交没有再次出现延迟。</blockquote></p><p> CEO Stanley Erck's interview with Yahoo! Finance Live last Thursday likely didn't help reassure investors. When asked about when the FDA filing would be done, Erck replied, \"It's probably going to be next week, but I'm sticking with the claim that we'll be doing this by the end of this year.\"</p><p><blockquote>首席执行官斯坦利·埃尔克接受雅虎采访！上周四的财经直播可能无助于安抚投资者。当被问及何时完成FDA备案时，Erck回答说：“可能是下周，但我坚持认为我们将在今年年底前完成这项工作。”</blockquote></p><p> <b>So what</b></p><p><blockquote><b>那又怎样</b></blockquote></p><p> Yet another delay in a U.S. filing for NVX-CoV2373 wouldn't be catastrophic for Novavax as long as the company completes the submission soon in the new year. However, management's credibility would definitely take another big blow.</p><p><blockquote>只要Novavax在新年尽快完成提交，NVX-CoV2373在美国的申请再次延迟对该公司来说不会是灾难性的。然而，管理层的信誉肯定会再次受到重大打击。</blockquote></p><p> But it's premature at this point to speculate that Novavax won't complete the U.S. EUA filing this week. It's also useless to fret about the quality of the company's FDA package. Novavax recently won European Union authorization for NVX-CoV2373. That shows that the vaccine maker can successfully meet regulators' manufacturing-quality hurdles.</p><p><blockquote>但目前推测Novavax本周不会完成美国EUA备案还为时过早。担心该公司FDA包装的质量也是没有用的。Novavax最近获得了NVX-CoV2373的欧盟授权。这表明疫苗制造商能够成功满足监管机构的生产质量障碍。</blockquote></p><p> <b>Now what</b></p><p><blockquote><b>现在怎么办</b></blockquote></p><p> Investors don't like waiting, but that's exactly what they'll have to do for now with Novavax. The company could complete its EUA filing any day now. It could also pick up new authorizations in other countries where it awaits regulatory decisions.</p><p><blockquote>投资者不喜欢等待，但这正是他们目前对Novavax必须做的事情。该公司现在可以随时完成EUA备案。它还可能在等待监管决定的其他国家获得新的授权。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1138246031","content_text":"Novavax shares dropped another 4% in premarket trading.The stock plunged nearly 11% yesterday.\n\nWhy Novavax Stock Is Sinking\nThe company didn't announce any new developments. So what's behind the big decline?\nOther vaccine stocks aren't falling nearly as much. Some were even up a little. That rules out the likelihood that declining concerns about the omicron variant played a major factor behind Novavax's drop.\nInstead, investors are probably growing more anxious about Novavax's planned filing for U.S. Emergency Use Authorization (EUA) of it COVID-19 vaccine NVX-CoV2373. Some investors could also be worried about the quality of Novavax's submission to the Food and Drug Administration (FDA) even if it doesn't experience another delay with the filing.\nCEO Stanley Erck's interview with Yahoo! Finance Live last Thursday likely didn't help reassure investors. When asked about when the FDA filing would be done, Erck replied, \"It's probably going to be next week, but I'm sticking with the claim that we'll be doing this by the end of this year.\"\nSo what\nYet another delay in a U.S. filing for NVX-CoV2373 wouldn't be catastrophic for Novavax as long as the company completes the submission soon in the new year. However, management's credibility would definitely take another big blow.\nBut it's premature at this point to speculate that Novavax won't complete the U.S. EUA filing this week. It's also useless to fret about the quality of the company's FDA package. Novavax recently won European Union authorization for NVX-CoV2373. That shows that the vaccine maker can successfully meet regulators' manufacturing-quality hurdles.\nNow what\nInvestors don't like waiting, but that's exactly what they'll have to do for now with Novavax. The company could complete its EUA filing any day now. It could also pick up new authorizations in other countries where it awaits regulatory decisions.","news_type":1,"symbols_score_info":{"NVAX":0.9}},"isVote":1,"tweetType":1,"viewCount":2875,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698432662,"gmtCreate":1640488189966,"gmtModify":1640488190120,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094269572113460","authorIdStr":"4094269572113460"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/698432662","repostId":"2193917872","repostType":4,"isVote":1,"tweetType":1,"viewCount":3160,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698217515,"gmtCreate":1640405186348,"gmtModify":1640405186490,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094269572113460","authorIdStr":"4094269572113460"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/698217515","repostId":"2193720178","repostType":4,"isVote":1,"tweetType":1,"viewCount":3608,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698333952,"gmtCreate":1640302602178,"gmtModify":1640302602541,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094269572113460","authorIdStr":"4094269572113460"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/698333952","repostId":"2193078140","repostType":4,"isVote":1,"tweetType":1,"viewCount":2662,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691270758,"gmtCreate":1640216306020,"gmtModify":1640216306127,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094269572113460","authorIdStr":"4094269572113460"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/691270758","repostId":"2193113147","repostType":4,"isVote":1,"tweetType":1,"viewCount":4094,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691954726,"gmtCreate":1640130161579,"gmtModify":1640130161850,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094269572113460","authorIdStr":"4094269572113460"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/691954726","repostId":"2193663561","repostType":4,"isVote":1,"tweetType":1,"viewCount":3823,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693724197,"gmtCreate":1640085463691,"gmtModify":1640085463794,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094269572113460","authorIdStr":"4094269572113460"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/693724197","repostId":"1173202355","repostType":2,"repost":{"id":"1173202355","kind":"news","pubTimestamp":1640053734,"share":"https://www.laohu8.com/m/news/1173202355?lang=zh_CN&edition=full","pubTime":"2021-12-21 10:28","market":"us","language":"en","title":"MRNA, NVAX, OCGN, PFE, BNTX: What Is Going on With Vaccine Stocks Today?<blockquote>MRNA、NVAX、OCGN、PFE、BNTX：今天疫苗股的情况如何？</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1173202355","media":"InvestorPlace","summary":"As another week kicks off on Wall Street, it’s clear that the ominous coverage of the spreading omic","content":"<p><div> As another week kicks off on Wall Street, it’s clear that the ominous coverage of the spreading omicron variant is still casting shadows over markets. This week has started off with mixed news ...</p><p><blockquote><div>随着华尔街又一周的开始，很明显，奥密克戎变种蔓延的不祥报道仍在给市场蒙上阴影。本周以喜忧参半的消息开始...</div></blockquote></p><p>  <a href=\"https://investorplace.com/2021/12/mrna-nvax-ocgn-pfe-bntx-what-is-going-on-with-vaccine-stocks-today/\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://investorplace.com/2021/12/mrna-nvax-ocgn-pfe-bntx-what-is-going-on-with-vaccine-stocks-today/\">网页连接</a></blockquote></p><p></p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MRNA, NVAX, OCGN, PFE, BNTX: What Is Going on With Vaccine Stocks Today?<blockquote>MRNA、NVAX、OCGN、PFE、BNTX：今天疫苗股的情况如何？</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMRNA, NVAX, OCGN, PFE, BNTX: What Is Going on With Vaccine Stocks Today?<blockquote>MRNA、NVAX、OCGN、PFE、BNTX：今天疫苗股的情况如何？</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">InvestorPlace</strong><span class=\"h-time small\">2021-12-21 10:28</span>\n</p>\n</h4>\n</header>\n<article>\n<p><div> As another week kicks off on Wall Street, it’s clear that the ominous coverage of the spreading omicron variant is still casting shadows over markets. This week has started off with mixed news ...</p><p><blockquote><div>随着华尔街又一周的开始，很明显，奥密克戎变种蔓延的不祥报道仍在给市场蒙上阴影。本周以喜忧参半的消息开始...</div></blockquote></p><p>  <a href=\"https://investorplace.com/2021/12/mrna-nvax-ocgn-pfe-bntx-what-is-going-on-with-vaccine-stocks-today/\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://investorplace.com/2021/12/mrna-nvax-ocgn-pfe-bntx-what-is-going-on-with-vaccine-stocks-today/\">网页连接</a></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://investorplace.com/2021/12/mrna-nvax-ocgn-pfe-bntx-what-is-going-on-with-vaccine-stocks-today/\">InvestorPlace</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc.","BNTX":"BioNTech SE","OCGN":"Ocugen","NVAX":"诺瓦瓦克斯医药","PFE":"辉瑞"},"source_url":"https://investorplace.com/2021/12/mrna-nvax-ocgn-pfe-bntx-what-is-going-on-with-vaccine-stocks-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1173202355","content_text":"As another week kicks off on Wall Street, it’s clear that the ominous coverage of the spreading omicron variant is still casting shadows over markets. This week has started off with mixed news surrounding the companies who are working around the clock to get ahead in the vaccine race. This has been making it difficult for the overall sector to gain the type of momentum it needs for all vaccine stocks to start moving upward. While one company has an encouraging update regarding its vaccine’s effectiveness against the variant, most of its peers haven’t been so lucky.\nWhat’s Going on With Vaccine Stocks?\nFor the companies embedded in the race to beat the variant, this week isn’t off to a good start. Indeed, vaccine stocks are facing noticeable turbulence.Moderna(NASDAQ:MRNA) began the day with the announcement that a third dose of its Covid-19 vaccine has been proven to increase antibodies against the new variant. Even with such reassuring news, MRNA stock is down 6.25% today. That said, it did cause shares to surge this morning, putting MRNA stock up almost 10% for the week.\nMeanwhile, most of its peers aren’t fairing much better.Novavax(NASDAQ:NVAX) just received authorization from the European Union to begin distributing its vaccine throughout Europe during the first half of 2022. While this news sent the stock up in premarket trading today, it hasn’t done much since then. NVAX stock is down more than 7% today. Additionally, Ocugen(NASDAQ:OCGN) is also falling after an initial early day rise driven by superficial catalysts.\nThe only vaccine stock in the green this morning is Pfizer(NYSE:PFE), which is up more than 2% today despite the recent setback the company experienced regarding its vaccine for children five years old and younger. Meanwhile, Pfizer’s vaccine production partner, Germany-based BioNTech(NASDAQ:BNTX) is down 4.19% so far, despite the recent news that the two companies will be providing more than 200 million additional vaccine doses to the EU in 2022.\nWhy It Matters\nWhile the week is off to a rough start, every company on this list is still up for the week. The only exception is OCGN, which seems more like a meme stock that is losing momentum.\nHowever, every other name on this list is fair game for a bullish play on vaccine stocks. The new data from Moderna is highly encouraging, in no small part because it likely means that Pfizer won’t be far behind in tailoring its own vaccine to effectively fight the omicron variant. Novavax’s news is also cause for optimism. While it hasn’t helped the stock rise this morning, it does suggest that global vaccine efforts are moving forward. The same could be said for the recent EU news regarding Pfizer and BioNTech. Novavax has been working hard to gain its place among the vaccine producers that helped us beat the pandemic’s earlier waves. And this looks like an opportunity for it to do exactly that.\nWhat It Means\nDespite today’s downturn, we will likely see another vaccine stock boom in 2022. Indeed, this will come as companies make real strides against the omicron variant.\nRegardless of exactly how that shakes out, world leaders are going to be working hard to speed up global vaccination efforts to ensure that new variants don’t emerge and complicate matters further. Every stock on this list, with the exception of OCGN, is worth watching as the new year takes shape.","news_type":1,"symbols_score_info":{"PFE":0.9,"BNTX":0.9,"MRNA":0.9,"OCGN":0.9,"NVAX":0.9}},"isVote":1,"tweetType":1,"viewCount":3888,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693917743,"gmtCreate":1639960563499,"gmtModify":1639960563638,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094269572113460","authorIdStr":"4094269572113460"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/693917743","repostId":"1154958924","repostType":4,"repost":{"id":"1154958924","kind":"news","pubTimestamp":1639958978,"share":"https://www.laohu8.com/m/news/1154958924?lang=zh_CN&edition=full","pubTime":"2021-12-20 08:09","market":"sg","language":"en","title":"Singapore Stock Market May Give Up Support At 3,100 Points<blockquote>新加坡股市或放弃3100点支撑</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1154958924","media":"RTTNews","summary":"The Singapore stock market has alternated between positive and negative finishes through the last fo","content":"<p>The Singapore stock market has alternated between positive and negative finishes through the last four trading days since the end of the two-day slide in which it had fallen more than 20 points or 0.7 percent. The Straits Times Index now sits just above the 3,110-point plateau and it may take further damage again on Monday.</p><p><blockquote>自连续两天下跌超过20点或0.7%以来，新加坡股市在过去四个交易日中涨跌互现。海峡时报指数目前略高于3,110点的高位，周一可能会再次遭受进一步损害。</blockquote></p><p> The global forecast for the Asian&nbsp;markets&nbsp;is soft on omicron coronavirus concerns and sinking oil prices. The European markets were mixed and the U.S. bourses were down and the Asian markets figure to split the difference.</p><p><blockquote>由于奥密克戎冠状病毒担忧和油价下跌，全球对亚洲市场的预测疲软。欧洲市场涨跌互现，美国股市下跌，亚洲市场似乎分担了这一差异。</blockquote></p><p> The STI finished modestly lower on Friday following losses from the industrials and properties, while the financials came in mixed.</p><p><blockquote>继工业和房地产股下跌后，海指周五小幅收低，而金融股则涨跌互现。</blockquote></p><p> For the day, the index lost 17.17 points or 0.55 percent to finish at the daily low of 3,111.63 after peaking at 3,134.99. Volume was 1.2 billion shares worth 1.5 billion Singapore dollars. There were 280 decliners and 188 gainers.</p><p><blockquote>当天，该指数下跌17.17点或0.55%，收于3111.63点的日低，此前曾触及3134.99点的高点。成交量为12亿股，价值15亿新元。下跌股280只，上涨股188只。</blockquote></p><p> Among the actives, CapitaLand Integrated Commercial Trust and Mapletree Commercial Trust both slumped 0.50 percent, while City Developments tanked 1.45 percent, Comfort DelGro lost 0.72 percent, Dairy Farm International slid 0.36 percent, DBS Group collected 0.34 percent, Genting Singapore fell 0.65 percent, Hongkong Land plummeted 2.07 percent, Keppel Corp and Venture Corporation both sank 0.97 percent, Mapletree Logistics Trust weakened 0.53 percent, Oversea-Chinese Banking Corporation eased 0.09 percent, SATS skidded 1.03 percent, SembCorp Industries plunged 1.49 percent, Singapore Airlines dropped 0.81 percent, Singapore Exchange tumbled 1.39 percent, Singapore Press Holdings added 0.43 percent, Singapore Technologies Engineering retreated 1.06 percent, SingTel stumbled 0.63 percent, Thai Beverage shed 0.75 percent, United Overseas Bank dipped 0.30 percent, Wilmar International declined 1.21 percent and Yangzijiang Shipbuilding and Ascendas REIT were unchanged.</p><p><blockquote>活跃股中，凯德综合商业信托和丰树商业信托均下跌0.50%，City Developments下跌1.45%，Comfort DelGro下跌0.72%，Dairy Farm International下跌0.36%，DBS Group上涨0.34%，云顶新加坡下跌0.65%，香港置地暴跌2.07%，吉宝企业和Venture Corporation均下跌0.97%，丰树物流信托下跌0.53%，华侨银行下跌0.03%，胜科工业下跌1.49%，新加坡航空下跌0.81%，新加坡报业控股上涨0.43%，新加坡科技工程下跌1.06%，新加坡电信下跌0.63%，泰国饮料下跌0.75%，丰益国际下跌1.21%，扬子江造船和腾飞房地产投资信托持平。</blockquote></p><p> The lead from Wall Street is negative as the major averages opened lower on a volatile Friday. The NASDAQ peeked briefly into the green but the markets all still finished in the red.</p><p><blockquote>华尔街的领先是负面的，因为主要股指在动荡的周五开盘走低。纳斯达克短暂出现绿色，但市场仍以红色收盘。</blockquote></p><p> The Dow plunged 532.16 points or 1.48 percent to finish at 35,365.44, while the NASDAQ dipped 10.72 points or 0.07 percent to close at 15,169.68 and the S&amp;P 500 sank 48.03 points or 1.03 percent to end at 4,620.64. For the week, the NASDAQ plunged 2.9 percent, the Dow lost 1.7 percent and the S&amp;P was down 1.9 percent.</p><p><blockquote>道琼斯指数下跌532.16点，跌幅1.48%，收于35,365.44点；纳斯达克下跌10.72点，跌幅0.07%，收于15,169.68点；标普500下跌48.03点，跌幅1.03%，收于4,620.64点。本周，纳斯达克暴跌2.9%，道琼斯指数下跌1.7%，标准普尔指数下跌1.9%。</blockquote></p><p> The volatility on Wall Street came on a quadruple witching day, with stock options, index options, stock futures and index futures all expiring.</p><p><blockquote>华尔街的波动发生在四重巫术日，股票期权、指数期权、股票期货和指数期货都将到期。</blockquote></p><p> Concerns about the impact of the Omicron variant of the&nbsp;coronavirus&nbsp;also weighed on the markets along with worries about ongoing supply chain issues.</p><p><blockquote>对冠状病毒奥密克戎变种影响的担忧以及对持续供应链问题的担忧也给市场带来压力。</blockquote></p><p> Crude oil prices tumbled Friday on concerns for energy demand due to a rapid surge in Omicron variant of the coronavirus and reimposition of restrictions. West Texas Intermediate Crude oil futures for January sank $1.52 or 2.1 percent at $70.86 a barrel. WTI crude futures shed 1.1 percent in the week.</p><p><blockquote>由于冠状病毒奥密克戎变种迅速激增和重新实施限制，对能源需求的担忧，原油价格周五暴跌。西德克萨斯中质原油1月期货下跌1.52美元，或2.1%，报每桶70.86美元。WTI原油期货本周下跌1.1%。</blockquote></p><p></p>","source":"lsy1626938412129","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Singapore Stock Market May Give Up Support At 3,100 Points<blockquote>新加坡股市或放弃3100点支撑</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSingapore Stock Market May Give Up Support At 3,100 Points<blockquote>新加坡股市或放弃3100点支撑</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">RTTNews</strong><span class=\"h-time small\">2021-12-20 08:09</span>\n</p>\n</h4>\n</header>\n<article>\n<p>The Singapore stock market has alternated between positive and negative finishes through the last four trading days since the end of the two-day slide in which it had fallen more than 20 points or 0.7 percent. The Straits Times Index now sits just above the 3,110-point plateau and it may take further damage again on Monday.</p><p><blockquote>自连续两天下跌超过20点或0.7%以来，新加坡股市在过去四个交易日中涨跌互现。海峡时报指数目前略高于3,110点的高位，周一可能会再次遭受进一步损害。</blockquote></p><p> The global forecast for the Asian&nbsp;markets&nbsp;is soft on omicron coronavirus concerns and sinking oil prices. The European markets were mixed and the U.S. bourses were down and the Asian markets figure to split the difference.</p><p><blockquote>由于奥密克戎冠状病毒担忧和油价下跌，全球对亚洲市场的预测疲软。欧洲市场涨跌互现，美国股市下跌，亚洲市场似乎分担了这一差异。</blockquote></p><p> The STI finished modestly lower on Friday following losses from the industrials and properties, while the financials came in mixed.</p><p><blockquote>继工业和房地产股下跌后，海指周五小幅收低，而金融股则涨跌互现。</blockquote></p><p> For the day, the index lost 17.17 points or 0.55 percent to finish at the daily low of 3,111.63 after peaking at 3,134.99. Volume was 1.2 billion shares worth 1.5 billion Singapore dollars. There were 280 decliners and 188 gainers.</p><p><blockquote>当天，该指数下跌17.17点或0.55%，收于3111.63点的日低，此前曾触及3134.99点的高点。成交量为12亿股，价值15亿新元。下跌股280只，上涨股188只。</blockquote></p><p> Among the actives, CapitaLand Integrated Commercial Trust and Mapletree Commercial Trust both slumped 0.50 percent, while City Developments tanked 1.45 percent, Comfort DelGro lost 0.72 percent, Dairy Farm International slid 0.36 percent, DBS Group collected 0.34 percent, Genting Singapore fell 0.65 percent, Hongkong Land plummeted 2.07 percent, Keppel Corp and Venture Corporation both sank 0.97 percent, Mapletree Logistics Trust weakened 0.53 percent, Oversea-Chinese Banking Corporation eased 0.09 percent, SATS skidded 1.03 percent, SembCorp Industries plunged 1.49 percent, Singapore Airlines dropped 0.81 percent, Singapore Exchange tumbled 1.39 percent, Singapore Press Holdings added 0.43 percent, Singapore Technologies Engineering retreated 1.06 percent, SingTel stumbled 0.63 percent, Thai Beverage shed 0.75 percent, United Overseas Bank dipped 0.30 percent, Wilmar International declined 1.21 percent and Yangzijiang Shipbuilding and Ascendas REIT were unchanged.</p><p><blockquote>活跃股中，凯德综合商业信托和丰树商业信托均下跌0.50%，City Developments下跌1.45%，Comfort DelGro下跌0.72%，Dairy Farm International下跌0.36%，DBS Group上涨0.34%，云顶新加坡下跌0.65%，香港置地暴跌2.07%，吉宝企业和Venture Corporation均下跌0.97%，丰树物流信托下跌0.53%，华侨银行下跌0.03%，胜科工业下跌1.49%，新加坡航空下跌0.81%，新加坡报业控股上涨0.43%，新加坡科技工程下跌1.06%，新加坡电信下跌0.63%，泰国饮料下跌0.75%，丰益国际下跌1.21%，扬子江造船和腾飞房地产投资信托持平。</blockquote></p><p> The lead from Wall Street is negative as the major averages opened lower on a volatile Friday. The NASDAQ peeked briefly into the green but the markets all still finished in the red.</p><p><blockquote>华尔街的领先是负面的，因为主要股指在动荡的周五开盘走低。纳斯达克短暂出现绿色，但市场仍以红色收盘。</blockquote></p><p> The Dow plunged 532.16 points or 1.48 percent to finish at 35,365.44, while the NASDAQ dipped 10.72 points or 0.07 percent to close at 15,169.68 and the S&amp;P 500 sank 48.03 points or 1.03 percent to end at 4,620.64. For the week, the NASDAQ plunged 2.9 percent, the Dow lost 1.7 percent and the S&amp;P was down 1.9 percent.</p><p><blockquote>道琼斯指数下跌532.16点，跌幅1.48%，收于35,365.44点；纳斯达克下跌10.72点，跌幅0.07%，收于15,169.68点；标普500下跌48.03点，跌幅1.03%，收于4,620.64点。本周，纳斯达克暴跌2.9%，道琼斯指数下跌1.7%，标准普尔指数下跌1.9%。</blockquote></p><p> The volatility on Wall Street came on a quadruple witching day, with stock options, index options, stock futures and index futures all expiring.</p><p><blockquote>华尔街的波动发生在四重巫术日，股票期权、指数期权、股票期货和指数期货都将到期。</blockquote></p><p> Concerns about the impact of the Omicron variant of the&nbsp;coronavirus&nbsp;also weighed on the markets along with worries about ongoing supply chain issues.</p><p><blockquote>对冠状病毒奥密克戎变种影响的担忧以及对持续供应链问题的担忧也给市场带来压力。</blockquote></p><p> Crude oil prices tumbled Friday on concerns for energy demand due to a rapid surge in Omicron variant of the coronavirus and reimposition of restrictions. West Texas Intermediate Crude oil futures for January sank $1.52 or 2.1 percent at $70.86 a barrel. WTI crude futures shed 1.1 percent in the week.</p><p><blockquote>由于冠状病毒奥密克戎变种迅速激增和重新实施限制，对能源需求的担忧，原油价格周五暴跌。西德克萨斯中质原油1月期货下跌1.52美元，或2.1%，报每桶70.86美元。WTI原油期货本周下跌1.1%。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.rttnews.com/3250329/singapore-stock-market-may-give-up-support-at-3100-points.aspx\">RTTNews</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"STI.SI":"富时新加坡海峡指数"},"source_url":"https://www.rttnews.com/3250329/singapore-stock-market-may-give-up-support-at-3100-points.aspx","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154958924","content_text":"The Singapore stock market has alternated between positive and negative finishes through the last four trading days since the end of the two-day slide in which it had fallen more than 20 points or 0.7 percent. The Straits Times Index now sits just above the 3,110-point plateau and it may take further damage again on Monday.\nThe global forecast for the Asian markets is soft on omicron coronavirus concerns and sinking oil prices. The European markets were mixed and the U.S. bourses were down and the Asian markets figure to split the difference.\nThe STI finished modestly lower on Friday following losses from the industrials and properties, while the financials came in mixed.\nFor the day, the index lost 17.17 points or 0.55 percent to finish at the daily low of 3,111.63 after peaking at 3,134.99. Volume was 1.2 billion shares worth 1.5 billion Singapore dollars. There were 280 decliners and 188 gainers.\nAmong the actives, CapitaLand Integrated Commercial Trust and Mapletree Commercial Trust both slumped 0.50 percent, while City Developments tanked 1.45 percent, Comfort DelGro lost 0.72 percent, Dairy Farm International slid 0.36 percent, DBS Group collected 0.34 percent, Genting Singapore fell 0.65 percent, Hongkong Land plummeted 2.07 percent, Keppel Corp and Venture Corporation both sank 0.97 percent, Mapletree Logistics Trust weakened 0.53 percent, Oversea-Chinese Banking Corporation eased 0.09 percent, SATS skidded 1.03 percent, SembCorp Industries plunged 1.49 percent, Singapore Airlines dropped 0.81 percent, Singapore Exchange tumbled 1.39 percent, Singapore Press Holdings added 0.43 percent, Singapore Technologies Engineering retreated 1.06 percent, SingTel stumbled 0.63 percent, Thai Beverage shed 0.75 percent, United Overseas Bank dipped 0.30 percent, Wilmar International declined 1.21 percent and Yangzijiang Shipbuilding and Ascendas REIT were unchanged.\nThe lead from Wall Street is negative as the major averages opened lower on a volatile Friday. The NASDAQ peeked briefly into the green but the markets all still finished in the red.\nThe Dow plunged 532.16 points or 1.48 percent to finish at 35,365.44, while the NASDAQ dipped 10.72 points or 0.07 percent to close at 15,169.68 and the S&P 500 sank 48.03 points or 1.03 percent to end at 4,620.64. For the week, the NASDAQ plunged 2.9 percent, the Dow lost 1.7 percent and the S&P was down 1.9 percent.\nThe volatility on Wall Street came on a quadruple witching day, with stock options, index options, stock futures and index futures all expiring.\nConcerns about the impact of the Omicron variant of the coronavirus also weighed on the markets along with worries about ongoing supply chain issues.\nCrude oil prices tumbled Friday on concerns for energy demand due to a rapid surge in Omicron variant of the coronavirus and reimposition of restrictions. West Texas Intermediate Crude oil futures for January sank $1.52 or 2.1 percent at $70.86 a barrel. WTI crude futures shed 1.1 percent in the week.","news_type":1,"symbols_score_info":{"STI.SI":0.9}},"isVote":1,"tweetType":1,"viewCount":4486,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699154850,"gmtCreate":1639758518349,"gmtModify":1639758518490,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094269572113460","authorIdStr":"4094269572113460"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/699154850","repostId":"2192497854","repostType":4,"isVote":1,"tweetType":1,"viewCount":2439,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690400755,"gmtCreate":1639698264965,"gmtModify":1639698265074,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094269572113460","authorIdStr":"4094269572113460"},"themes":[],"htmlText":"Pls like&nbsp;","listText":"Pls like&nbsp;","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/690400755","repostId":"2192942001","repostType":4,"isVote":1,"tweetType":1,"viewCount":526,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690090549,"gmtCreate":1639611551274,"gmtModify":1639611551369,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094269572113460","authorIdStr":"4094269572113460"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/690090549","repostId":"2191997591","repostType":4,"isVote":1,"tweetType":1,"viewCount":759,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607882573,"gmtCreate":1639525208395,"gmtModify":1639525208529,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094269572113460","authorIdStr":"4094269572113460"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/607882573","repostId":"2191784951","repostType":4,"isVote":1,"tweetType":1,"viewCount":901,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607018788,"gmtCreate":1639456582644,"gmtModify":1639456582739,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094269572113460","authorIdStr":"4094269572113460"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/607018788","repostId":"2191811539","repostType":4,"isVote":1,"tweetType":1,"viewCount":616,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607018423,"gmtCreate":1639456552564,"gmtModify":1639456552655,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094269572113460","authorIdStr":"4094269572113460"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>up or down","listText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>up or down","text":"$Apple(AAPL)$up or down","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607018423","isVote":1,"tweetType":1,"viewCount":913,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604981931,"gmtCreate":1639308573334,"gmtModify":1639308573430,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094269572113460","authorIdStr":"4094269572113460"},"themes":[],"htmlText":"Pls like&nbsp;","listText":"Pls like&nbsp;","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/604981931","repostId":"2190679207","repostType":4,"isVote":1,"tweetType":1,"viewCount":1366,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605560500,"gmtCreate":1639191679818,"gmtModify":1639191679952,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094269572113460","authorIdStr":"4094269572113460"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/605560500","repostId":"1122303970","repostType":4,"repost":{"id":"1122303970","kind":"news","pubTimestamp":1639135689,"share":"https://www.laohu8.com/m/news/1122303970?lang=zh_CN&edition=full","pubTime":"2021-12-10 19:28","market":"us","language":"en","title":"Is It Time to Buy the Dow's 3 Worst Performing Stocks This Year?<blockquote>是时候买入道琼斯指数今年表现最差的3只股票了吗？</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1122303970","media":"Motley Fool","summary":"Take a look to see if these dogs of the Dow are worth buying.","content":"<p>The&nbsp;<b>Dow Jones Industrial Average</b>&nbsp;is an index made up of 30 of the largest and most influential companies on U.S. stock exchanges. The index has historically returned around 7.5% each year, so being up over 15% makes 2021 a year to celebrate.</p><p><blockquote>The<b>道琼斯工业平均指数</b>是一个由美国证券交易所30家最大、最具影响力的公司组成的指数。该指数历史上每年的回报率约为7.5%，因此上涨超过15%使2021年成为值得庆祝的一年。</blockquote></p><p> Not every stock in the Dow Jones has performed well. The three stocks we'll discuss are all down and have been since the beginning of 2021, despite the index being up so much. We'll look at each one to determine whether they represent an opportunity or are down for a good reason.</p><p><blockquote>并非道琼斯指数中的每只股票都表现良好。尽管该指数上涨了很多，但我们将讨论的三只股票自2021年初以来都在下跌。我们将研究每一个，以确定它们是代表一个机会还是有充分理由的。</blockquote></p><p> <b>1. Amgen</b></p><p><blockquote><b>1.安进</b></blockquote></p><p> Biotech company&nbsp;<b>Amgen</b>&nbsp;has been down about 7% since the beginning of 2021. The company develops and sells drugs aimed at inflammation, cancer, bone health, heart disease, and more.</p><p><blockquote>生物技术公司<b>安进</b>自2021年初以来已下跌约7%。该公司开发和销售针对炎症、癌症、骨骼健康、心脏病等疾病的药物。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/115c1a57215446a5a83d447ffbb995ca\" tg-width=\"2000\" tg-height=\"1333\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图片来源：盖蒂图片社。</span></p></blockquote></p><p> When a company invents a successful drug, its formula is patented, protecting it from direct competition for many years. Medications can cost millions of dollars to research and develop but can fail when tested in trials. A successful drug sometimes referred to as a blockbuster, can bring in billions in revenue over the length of its patent.</p><p><blockquote>当一家公司发明了一种成功的药物时，它的配方就会获得专利，保护它多年来免受直接竞争。药物的研发可能花费数百万美元，但在试验中测试时可能会失败。一种成功的药物有时被称为重磅炸弹，在其专利期限内可以带来数十亿美元的收入。</blockquote></p><p> Investors can get a feel for the trajectory of a drug company by following when its key products lose their patent protection. Once this happens, generic competitors flood the market at lower prices, significantly reducing the original drug's sales.</p><p><blockquote>投资者可以通过跟踪制药公司的关键产品何时失去专利保护来了解其发展轨迹。一旦发生这种情况，仿制药竞争对手就会以更低的价格涌入市场，从而大幅降低原研药的销量。</blockquote></p><p> Many of Amgen's primary products could lose sales when their patents expire:</p><p><blockquote>当专利到期时，安进的许多主要产品可能会失去销售：</blockquote></p><p> <ul>  <li>Enbrel (19% of revenue) expires in the U.S. in 2029.</li>  <li>Prolia (12% of revenue) expires in the U.S. in 2025.</li>  <li>Otezla (9% of revenue) expires in the U.S. in 2028.</li>  <li>Xgeva (8% of revenue) expires in the U.S. in 2025.</li> </ul> The United States has a more-complicated patent system, where drug companies can extend their patents by making minor changes to them. This, combined with the high drug prices charged in the U.S. market, is why domestic sales account for 68% of Amgen's global revenue. As these patents expire over the next decade, the company will&nbsp;need its pipeline to deliver&nbsp;successful products to replace this lost revenue.</p><p><blockquote><ul><li>Enbrel（占收入的19%）将于2029年在美国到期。</li><li>Prolia（占收入的12%）将于2025年在美国到期。</li><li>Otezla（占收入的9%）将于2028年在美国到期。</li><li>Xgeva（占收入的8%）将于2025年在美国到期。</li></ul>美国有一个更复杂的专利制度，制药公司可以通过对专利进行微小的修改来延长专利。这一点，再加上美国市场收取的高昂药价，就是为什么国内销售额占安进全球收入的68%。随着这些专利在未来十年到期，该公司将需要其管道来提供成功的产品来弥补收入损失。</blockquote></p><p> The stock currently trades at a&nbsp;price-to-earnings ratio&nbsp;(P/E) of 12 using analyst estimates for 2021&nbsp;earnings per share&nbsp;(EPS), far less than its historical average of 17. Analysts are calling for growth of 8% per year over the next three to five years, and pharmaceutical companies face political pressure in the United States due to drug prices. These risks probably justify a discounted valuation, and that's just what the stock offers at these levels.</p><p><blockquote>根据分析师对2021年每股收益(EPS)的估计，该股目前的市盈率(P/E)为12，远低于17的历史平均水平。分析师呼吁未来三到五年每年增长8%，制药公司在美国面临药价问题的政治压力。这些风险可能证明估值折扣是合理的，而这正是该股票在这些水平上所提供的。</blockquote></p><p> <b>Verdict: thumbs-up</b></p><p><blockquote><b>结论：竖起大拇指</b></blockquote></p><p> <b>2. Merck</b></p><p><blockquote><b>2.默克</b></blockquote></p><p> A rival to Amgen,<b>Merck</b>&nbsp;develops drugs for cancer, immunology, and virology, as well as vaccine products, along with a separate business unit that develops drugs for veterinary use. The stock has maintained its 11% decline since the beginning of the year.</p><p><blockquote>安进的竞争对手，<b>默克</b>开发癌症、免疫学和病毒学药物以及疫苗产品，以及一个开发兽医用药物的独立业务部门。该股自年初以来一直保持着11%的跌幅。</blockquote></p><p> Merck doesn't have a patent cliff that's quite as imminent as Amgen's. Its Januvia/Janumet accounts for about 10% of sales, and its patent expires in 2022, but the patents for the rest of Merck's significant drugs like Keytruda (34% of revenue) and Gardasil (15% of revenue) don't expire until 2028.</p><p><blockquote>默克并不像安进那样面临迫在眉睫的专利悬崖。其Januvia/Janumet约占销售额的10%，其专利将于2022年到期，但默克其余重要药物如Keytruda（占收入的34%）和Gardasil（占收入的15%）的专利不会到期直到2028年。</blockquote></p><p> The company also released positive results from its clinical trials on molnupiravir, a pill that, when taken at the early stages of COVID-19 infection, can reduce the risk of serious illness by 30%. Merck has already agreed to sell more than $2.2 billion in treatments, so as the omicron variant continues to spread, it could give a spark to Merck's business. Rival&nbsp;<b>Pfizer</b>&nbsp;is also bringing a similar pill to market, but there could be&nbsp;enough demand for both to succeedhere.</p><p><blockquote>该公司还发布了molnupiravir临床试验的积极结果，molnupiravir是一种在COVID-19感染早期服用的药物，可以将患严重疾病的风险降低30%。默克已经同意出售超过22亿美元的治疗药物，因此随着奥密克戎病毒变种的继续传播，它可能会给默克的业务带来火花。竞争对手<b>辉瑞</b>也将一种类似的药丸推向市场，但两者都可能有足够的需求来取得成功。</blockquote></p><p> The stock is trading at a P/E of 11, a significant discount to its historical P/E of 27. Analysts are calling for modest growth of 6% per year over the next three to five years, but that might be conservative due to COVID treatments. Investors might not be factoring in the potential business from the COVID pill, and the valuation markdown could provide a margin of safety.</p><p><blockquote>该股目前的市盈率为11，较其历史市盈率27大幅折扣。分析师预计未来三到五年每年温和增长6%，但由于新冠病毒治疗，这可能是保守的。投资者可能不会考虑新冠药物的潜在业务，估值下降可能会提供安全边际。</blockquote></p><p> <b>Verdict: thumbs-up</b></p><p><blockquote><b>结论：竖起大拇指</b></blockquote></p><p> <b>3. Verizon Communications</b></p><p><blockquote><b>3.威瑞森通信</b></blockquote></p><p> Down 14% year to date, telecom company&nbsp;<b>Verizon Communications</b>&nbsp;is among a select few companies that control the wireless networks in the United States. The infrastructure that supports our nationwide phone network costs billions of dollars and took years to build out, so there is a minor threat from outside competition, even with fierce competitors like&nbsp;<b>AT&amp;T</b>&nbsp;and&nbsp;<b>T-Mobile</b>.</p><p><blockquote>电信公司今年迄今下跌14%<b>Verizon通信</b>是少数几家控制美国无线网络的公司之一。支持我们全国电话网络的基础设施耗资数十亿美元，花了数年时间才建成，因此来自外部竞争的威胁很小，即使有像<b>AT&amp;T</b>和<b>T-Mobile</b>.</blockquote></p><p></p><p> The stock trades at a P/E of just over 9 based on 2021 EPS estimates. This is a bargain valuation if we look at its historical average, 14. While many would assume that 5G technology would unlock a lot of growth, Verizon has historically been a slow-growing business even with the emergence of 3G and 4G networks over time.</p><p><blockquote>根据2021年每股收益预测，该股的市盈率略高于9。如果我们看看其历史平均水平14，这是一个便宜的估值。虽然许多人认为5G技术将带来大量增长，但即使随着时间的推移出现了3G和4G网络，威瑞森在历史上一直是一家增长缓慢的企业。</blockquote></p><p> Analysts estimate the company's three-to-five-year EPS growth at around 3% annually. Defensive investors who want a solid dividend can benefit here: It pays a dividend that yields 5% and needs just half of its profits to afford that payment. Investors focused on total returns probably won't get excited about Verizon, even at this reduced valuation.</p><p><blockquote>分析师预计该公司三到五年的每股收益年增长率约为3%。想要稳定股息的防御性投资者可以从这里受益：它支付的股息收益率为5%，并且只需要一半的利润就可以支付这笔款项。关注总回报的投资者可能不会对Verizon感到兴奋，即使估值较低。</blockquote></p><p> <b>Verdict: thumbs-down</b></p><p><blockquote><b>结论：反对</b></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is It Time to Buy the Dow's 3 Worst Performing Stocks This Year?<blockquote>是时候买入道琼斯指数今年表现最差的3只股票了吗？</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs It Time to Buy the Dow's 3 Worst Performing Stocks This Year?<blockquote>是时候买入道琼斯指数今年表现最差的3只股票了吗？</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Motley Fool</strong><span class=\"h-time small\">2021-12-10 19:28</span>\n</p>\n</h4>\n</header>\n<article>\n<p>The&nbsp;<b>Dow Jones Industrial Average</b>&nbsp;is an index made up of 30 of the largest and most influential companies on U.S. stock exchanges. The index has historically returned around 7.5% each year, so being up over 15% makes 2021 a year to celebrate.</p><p><blockquote>The<b>道琼斯工业平均指数</b>是一个由美国证券交易所30家最大、最具影响力的公司组成的指数。该指数历史上每年的回报率约为7.5%，因此上涨超过15%使2021年成为值得庆祝的一年。</blockquote></p><p> Not every stock in the Dow Jones has performed well. The three stocks we'll discuss are all down and have been since the beginning of 2021, despite the index being up so much. We'll look at each one to determine whether they represent an opportunity or are down for a good reason.</p><p><blockquote>并非道琼斯指数中的每只股票都表现良好。尽管该指数上涨了很多，但我们将讨论的三只股票自2021年初以来都在下跌。我们将研究每一个，以确定它们是代表一个机会还是有充分理由的。</blockquote></p><p> <b>1. Amgen</b></p><p><blockquote><b>1.安进</b></blockquote></p><p> Biotech company&nbsp;<b>Amgen</b>&nbsp;has been down about 7% since the beginning of 2021. The company develops and sells drugs aimed at inflammation, cancer, bone health, heart disease, and more.</p><p><blockquote>生物技术公司<b>安进</b>自2021年初以来已下跌约7%。该公司开发和销售针对炎症、癌症、骨骼健康、心脏病等疾病的药物。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/115c1a57215446a5a83d447ffbb995ca\" tg-width=\"2000\" tg-height=\"1333\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图片来源：盖蒂图片社。</span></p></blockquote></p><p> When a company invents a successful drug, its formula is patented, protecting it from direct competition for many years. Medications can cost millions of dollars to research and develop but can fail when tested in trials. A successful drug sometimes referred to as a blockbuster, can bring in billions in revenue over the length of its patent.</p><p><blockquote>当一家公司发明了一种成功的药物时，它的配方就会获得专利，保护它多年来免受直接竞争。药物的研发可能花费数百万美元，但在试验中测试时可能会失败。一种成功的药物有时被称为重磅炸弹，在其专利期限内可以带来数十亿美元的收入。</blockquote></p><p> Investors can get a feel for the trajectory of a drug company by following when its key products lose their patent protection. Once this happens, generic competitors flood the market at lower prices, significantly reducing the original drug's sales.</p><p><blockquote>投资者可以通过跟踪制药公司的关键产品何时失去专利保护来了解其发展轨迹。一旦发生这种情况，仿制药竞争对手就会以更低的价格涌入市场，从而大幅降低原研药的销量。</blockquote></p><p> Many of Amgen's primary products could lose sales when their patents expire:</p><p><blockquote>当专利到期时，安进的许多主要产品可能会失去销售：</blockquote></p><p> <ul>  <li>Enbrel (19% of revenue) expires in the U.S. in 2029.</li>  <li>Prolia (12% of revenue) expires in the U.S. in 2025.</li>  <li>Otezla (9% of revenue) expires in the U.S. in 2028.</li>  <li>Xgeva (8% of revenue) expires in the U.S. in 2025.</li> </ul> The United States has a more-complicated patent system, where drug companies can extend their patents by making minor changes to them. This, combined with the high drug prices charged in the U.S. market, is why domestic sales account for 68% of Amgen's global revenue. As these patents expire over the next decade, the company will&nbsp;need its pipeline to deliver&nbsp;successful products to replace this lost revenue.</p><p><blockquote><ul><li>Enbrel（占收入的19%）将于2029年在美国到期。</li><li>Prolia（占收入的12%）将于2025年在美国到期。</li><li>Otezla（占收入的9%）将于2028年在美国到期。</li><li>Xgeva（占收入的8%）将于2025年在美国到期。</li></ul>美国有一个更复杂的专利制度，制药公司可以通过对专利进行微小的修改来延长专利。这一点，再加上美国市场收取的高昂药价，就是为什么国内销售额占安进全球收入的68%。随着这些专利在未来十年到期，该公司将需要其管道来提供成功的产品来弥补收入损失。</blockquote></p><p> The stock currently trades at a&nbsp;price-to-earnings ratio&nbsp;(P/E) of 12 using analyst estimates for 2021&nbsp;earnings per share&nbsp;(EPS), far less than its historical average of 17. Analysts are calling for growth of 8% per year over the next three to five years, and pharmaceutical companies face political pressure in the United States due to drug prices. These risks probably justify a discounted valuation, and that's just what the stock offers at these levels.</p><p><blockquote>根据分析师对2021年每股收益(EPS)的估计，该股目前的市盈率(P/E)为12，远低于17的历史平均水平。分析师呼吁未来三到五年每年增长8%，制药公司在美国面临药价问题的政治压力。这些风险可能证明估值折扣是合理的，而这正是该股票在这些水平上所提供的。</blockquote></p><p> <b>Verdict: thumbs-up</b></p><p><blockquote><b>结论：竖起大拇指</b></blockquote></p><p> <b>2. Merck</b></p><p><blockquote><b>2.默克</b></blockquote></p><p> A rival to Amgen,<b>Merck</b>&nbsp;develops drugs for cancer, immunology, and virology, as well as vaccine products, along with a separate business unit that develops drugs for veterinary use. The stock has maintained its 11% decline since the beginning of the year.</p><p><blockquote>安进的竞争对手，<b>默克</b>开发癌症、免疫学和病毒学药物以及疫苗产品，以及一个开发兽医用药物的独立业务部门。该股自年初以来一直保持着11%的跌幅。</blockquote></p><p> Merck doesn't have a patent cliff that's quite as imminent as Amgen's. Its Januvia/Janumet accounts for about 10% of sales, and its patent expires in 2022, but the patents for the rest of Merck's significant drugs like Keytruda (34% of revenue) and Gardasil (15% of revenue) don't expire until 2028.</p><p><blockquote>默克并不像安进那样面临迫在眉睫的专利悬崖。其Januvia/Janumet约占销售额的10%，其专利将于2022年到期，但默克其余重要药物如Keytruda（占收入的34%）和Gardasil（占收入的15%）的专利不会到期直到2028年。</blockquote></p><p> The company also released positive results from its clinical trials on molnupiravir, a pill that, when taken at the early stages of COVID-19 infection, can reduce the risk of serious illness by 30%. Merck has already agreed to sell more than $2.2 billion in treatments, so as the omicron variant continues to spread, it could give a spark to Merck's business. Rival&nbsp;<b>Pfizer</b>&nbsp;is also bringing a similar pill to market, but there could be&nbsp;enough demand for both to succeedhere.</p><p><blockquote>该公司还发布了molnupiravir临床试验的积极结果，molnupiravir是一种在COVID-19感染早期服用的药物，可以将患严重疾病的风险降低30%。默克已经同意出售超过22亿美元的治疗药物，因此随着奥密克戎病毒变种的继续传播，它可能会给默克的业务带来火花。竞争对手<b>辉瑞</b>也将一种类似的药丸推向市场，但两者都可能有足够的需求来取得成功。</blockquote></p><p> The stock is trading at a P/E of 11, a significant discount to its historical P/E of 27. Analysts are calling for modest growth of 6% per year over the next three to five years, but that might be conservative due to COVID treatments. Investors might not be factoring in the potential business from the COVID pill, and the valuation markdown could provide a margin of safety.</p><p><blockquote>该股目前的市盈率为11，较其历史市盈率27大幅折扣。分析师预计未来三到五年每年温和增长6%，但由于新冠病毒治疗，这可能是保守的。投资者可能不会考虑新冠药物的潜在业务，估值下降可能会提供安全边际。</blockquote></p><p> <b>Verdict: thumbs-up</b></p><p><blockquote><b>结论：竖起大拇指</b></blockquote></p><p> <b>3. Verizon Communications</b></p><p><blockquote><b>3.威瑞森通信</b></blockquote></p><p> Down 14% year to date, telecom company&nbsp;<b>Verizon Communications</b>&nbsp;is among a select few companies that control the wireless networks in the United States. The infrastructure that supports our nationwide phone network costs billions of dollars and took years to build out, so there is a minor threat from outside competition, even with fierce competitors like&nbsp;<b>AT&amp;T</b>&nbsp;and&nbsp;<b>T-Mobile</b>.</p><p><blockquote>电信公司今年迄今下跌14%<b>Verizon通信</b>是少数几家控制美国无线网络的公司之一。支持我们全国电话网络的基础设施耗资数十亿美元，花了数年时间才建成，因此来自外部竞争的威胁很小，即使有像<b>AT&amp;T</b>和<b>T-Mobile</b>.</blockquote></p><p></p><p> The stock trades at a P/E of just over 9 based on 2021 EPS estimates. This is a bargain valuation if we look at its historical average, 14. While many would assume that 5G technology would unlock a lot of growth, Verizon has historically been a slow-growing business even with the emergence of 3G and 4G networks over time.</p><p><blockquote>根据2021年每股收益预测，该股的市盈率略高于9。如果我们看看其历史平均水平14，这是一个便宜的估值。虽然许多人认为5G技术将带来大量增长，但即使随着时间的推移出现了3G和4G网络，威瑞森在历史上一直是一家增长缓慢的企业。</blockquote></p><p> Analysts estimate the company's three-to-five-year EPS growth at around 3% annually. Defensive investors who want a solid dividend can benefit here: It pays a dividend that yields 5% and needs just half of its profits to afford that payment. Investors focused on total returns probably won't get excited about Verizon, even at this reduced valuation.</p><p><blockquote>分析师预计该公司三到五年的每股收益年增长率约为3%。想要稳定股息的防御性投资者可以从这里受益：它支付的股息收益率为5%，并且只需要一半的利润就可以支付这笔款项。关注总回报的投资者可能不会对Verizon感到兴奋，即使估值较低。</blockquote></p><p> <b>Verdict: thumbs-down</b></p><p><blockquote><b>结论：反对</b></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.fool.com/investing/2021/12/10/is-it-time-to-buy-the-dow-jones-3-worst-performing/\">Motley Fool</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VZ":"Verizon Comms","MRK":"默沙东","AMGN":"安进"},"source_url":"https://www.fool.com/investing/2021/12/10/is-it-time-to-buy-the-dow-jones-3-worst-performing/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122303970","content_text":"The Dow Jones Industrial Average is an index made up of 30 of the largest and most influential companies on U.S. stock exchanges. The index has historically returned around 7.5% each year, so being up over 15% makes 2021 a year to celebrate.\nNot every stock in the Dow Jones has performed well. The three stocks we'll discuss are all down and have been since the beginning of 2021, despite the index being up so much. We'll look at each one to determine whether they represent an opportunity or are down for a good reason.\n1. Amgen\nBiotech company Amgen has been down about 7% since the beginning of 2021. The company develops and sells drugs aimed at inflammation, cancer, bone health, heart disease, and more.\nImage source: Getty Images.\nWhen a company invents a successful drug, its formula is patented, protecting it from direct competition for many years. Medications can cost millions of dollars to research and develop but can fail when tested in trials. A successful drug sometimes referred to as a blockbuster, can bring in billions in revenue over the length of its patent.\nInvestors can get a feel for the trajectory of a drug company by following when its key products lose their patent protection. Once this happens, generic competitors flood the market at lower prices, significantly reducing the original drug's sales.\nMany of Amgen's primary products could lose sales when their patents expire:\n\nEnbrel (19% of revenue) expires in the U.S. in 2029.\nProlia (12% of revenue) expires in the U.S. in 2025.\nOtezla (9% of revenue) expires in the U.S. in 2028.\nXgeva (8% of revenue) expires in the U.S. in 2025.\n\nThe United States has a more-complicated patent system, where drug companies can extend their patents by making minor changes to them. This, combined with the high drug prices charged in the U.S. market, is why domestic sales account for 68% of Amgen's global revenue. As these patents expire over the next decade, the company will need its pipeline to deliver successful products to replace this lost revenue.\nThe stock currently trades at a price-to-earnings ratio (P/E) of 12 using analyst estimates for 2021 earnings per share (EPS), far less than its historical average of 17. Analysts are calling for growth of 8% per year over the next three to five years, and pharmaceutical companies face political pressure in the United States due to drug prices. These risks probably justify a discounted valuation, and that's just what the stock offers at these levels.\nVerdict: thumbs-up\n2. Merck\nA rival to Amgen,Merck develops drugs for cancer, immunology, and virology, as well as vaccine products, along with a separate business unit that develops drugs for veterinary use. The stock has maintained its 11% decline since the beginning of the year.\nMerck doesn't have a patent cliff that's quite as imminent as Amgen's. Its Januvia/Janumet accounts for about 10% of sales, and its patent expires in 2022, but the patents for the rest of Merck's significant drugs like Keytruda (34% of revenue) and Gardasil (15% of revenue) don't expire until 2028.\nThe company also released positive results from its clinical trials on molnupiravir, a pill that, when taken at the early stages of COVID-19 infection, can reduce the risk of serious illness by 30%. Merck has already agreed to sell more than $2.2 billion in treatments, so as the omicron variant continues to spread, it could give a spark to Merck's business. Rival Pfizer is also bringing a similar pill to market, but there could be enough demand for both to succeedhere.\nThe stock is trading at a P/E of 11, a significant discount to its historical P/E of 27. Analysts are calling for modest growth of 6% per year over the next three to five years, but that might be conservative due to COVID treatments. Investors might not be factoring in the potential business from the COVID pill, and the valuation markdown could provide a margin of safety.\nVerdict: thumbs-up\n3. Verizon Communications\nDown 14% year to date, telecom company Verizon Communications is among a select few companies that control the wireless networks in the United States. The infrastructure that supports our nationwide phone network costs billions of dollars and took years to build out, so there is a minor threat from outside competition, even with fierce competitors like AT&T and T-Mobile.\nThe stock trades at a P/E of just over 9 based on 2021 EPS estimates. This is a bargain valuation if we look at its historical average, 14. While many would assume that 5G technology would unlock a lot of growth, Verizon has historically been a slow-growing business even with the emergence of 3G and 4G networks over time.\nAnalysts estimate the company's three-to-five-year EPS growth at around 3% annually. Defensive investors who want a solid dividend can benefit here: It pays a dividend that yields 5% and needs just half of its profits to afford that payment. Investors focused on total returns probably won't get excited about Verizon, even at this reduced valuation.\nVerdict: thumbs-down","news_type":1,"symbols_score_info":{"VZ":0.9,"MRK":0.9,"AMGN":0.9}},"isVote":1,"tweetType":1,"viewCount":813,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605082821,"gmtCreate":1639093559363,"gmtModify":1639093559460,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094269572113460","authorIdStr":"4094269572113460"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/605082821","repostId":"1168862300","repostType":4,"isVote":1,"tweetType":1,"viewCount":736,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602529513,"gmtCreate":1639043966849,"gmtModify":1639043966947,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094269572113460","authorIdStr":"4094269572113460"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/602529513","repostId":"2189667447","repostType":4,"isVote":1,"tweetType":1,"viewCount":781,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602038601,"gmtCreate":1638937668197,"gmtModify":1638937668319,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094269572113460","authorIdStr":"4094269572113460"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/602038601","repostId":"1180884235","repostType":4,"repost":{"id":"1180884235","kind":"news","pubTimestamp":1638932278,"share":"https://www.laohu8.com/m/news/1180884235?lang=zh_CN&edition=full","pubTime":"2021-12-08 10:57","market":"us","language":"en","title":"Dear NIO Stock Fans, Mark Your Calendars for This Potential Catalyst on Dec. 18<blockquote>亲爱的蔚来股票粉丝，请在您的日历上标记12月18日的这一潜在催化剂</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1180884235","media":"InvestorPlace","summary":"Fans of electric vehicle  stocks are anxiously awaiting Nio Day, which has been confirmed to take place on Dec. 18 in Suzhou, China.Nio is expected to debut at least two new vehicle models and possibly a brand new vehicle brand. During Nio Day 2020, the EV maker unveiled the ET7 sedan to much fanfare. Deliveries for the ET7 sedan are expected to start in 2022 for most countries, although confirmation for this timetable will likely be answered at Nio Day.Without further ado, let’s dive right into","content":"<p><div> Fans of electric vehicle (EV) stocks are anxiously awaiting Nio Day, which has been confirmed to take place on Dec. 18 in Suzhou, China.Nio(NYSE:NIO) is expected to debut at least two new vehicle ...</p><p><blockquote><div>电动汽车（EV）股票的粉丝们正在焦急地等待蔚来日，该日已确认将于12月18日在中国苏州市举行。蔚来汽车（纽约证券交易所股票代码：蔚来）预计将推出至少两款新车……</div></blockquote></p><p>  <a href=\"https://investorplace.com/2021/12/dear-nio-stock-fans-mark-your-calendars-for-this-potential-catalyst/\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://investorplace.com/2021/12/dear-nio-stock-fans-mark-your-calendars-for-this-potential-catalyst/\">网页连接</a></blockquote></p><p></p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dear NIO Stock Fans, Mark Your Calendars for This Potential Catalyst on Dec. 18<blockquote>亲爱的蔚来股票粉丝，请在您的日历上标记12月18日的这一潜在催化剂</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDear NIO Stock Fans, Mark Your Calendars for This Potential Catalyst on Dec. 18<blockquote>亲爱的蔚来股票粉丝，请在您的日历上标记12月18日的这一潜在催化剂</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">InvestorPlace</strong><span class=\"h-time small\">2021-12-08 10:57</span>\n</p>\n</h4>\n</header>\n<article>\n<p><div> Fans of electric vehicle (EV) stocks are anxiously awaiting Nio Day, which has been confirmed to take place on Dec. 18 in Suzhou, China.Nio(NYSE:NIO) is expected to debut at least two new vehicle ...</p><p><blockquote><div>电动汽车（EV）股票的粉丝们正在焦急地等待蔚来日，该日已确认将于12月18日在中国苏州市举行。蔚来汽车（纽约证券交易所股票代码：蔚来）预计将推出至少两款新车……</div></blockquote></p><p>  <a href=\"https://investorplace.com/2021/12/dear-nio-stock-fans-mark-your-calendars-for-this-potential-catalyst/\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://investorplace.com/2021/12/dear-nio-stock-fans-mark-your-calendars-for-this-potential-catalyst/\">网页连接</a></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://investorplace.com/2021/12/dear-nio-stock-fans-mark-your-calendars-for-this-potential-catalyst/\">InvestorPlace</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NIO":"蔚来"},"source_url":"https://investorplace.com/2021/12/dear-nio-stock-fans-mark-your-calendars-for-this-potential-catalyst/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1180884235","content_text":"Fans of electric vehicle (EV) stocks are anxiously awaiting Nio Day, which has been confirmed to take place on Dec. 18 in Suzhou, China.Nio(NYSE:NIO) is expected to debut at least two new vehicle models and possibly a brand new vehicle brand. During Nio Day 2020, the EV maker unveiled the ET7 sedan to much fanfare. Deliveries for the ET7 sedan are expected to start in 2022 for most countries, although confirmation for this timetable will likely be answered at Nio Day.\nNio also impressed shareholders after releasing its November delivery numbers. The company reported that it had delivered 10,878 vehicles, up nearly 106% year-over-year (YOY). This brings total year deliveries to 80,940 vehicles, up more than 120% YOY. The November numbers were much needed after Nio reported disappointing October deliveries. Those numbers came in lower due to supply-chain issues and chip shortages.InvestorPlacecontributor Vandita Jadeja notes that Nio’sexpected fourth-quarter deliveries of 23,500 to 25,500 vehicles will be difficult to accomplish.\nWithout further ado, let’s dive right into what investors should know about Nio’s most exciting day of the year.\nNio Day: What NIO Stock Investors Should Know\n\nRumors are flying around that one of the new vehicles to be released during Nio Day is the ET5, a mid-sized sedan. The ET5 will reportedly compete with the BMW(OTCMKTS:BMWYY) 3-series and the Audi A4 at a lower price (Audi is owned by Volkswagen(OTCMKTS:VWAGY)).\nThe ET5 will likely be priced below the ET7, which has a base cost of around $69,000.\nAccording to a research note from Deutsche Bank, the second mystery EV is expected to be similar to the Toyota(NYSE:TM) Alphard, a luxury multi-purpose vehicle (MPV) that “sold 20,000 units in China last year.” Deutsche’s second guess is a high-performance sports coupe.\nNio recently filed a trademark registration for the name EF9, according to Electric Vehicle Web. This has led many to speculate that the new vehicle will be a convertible version of the EP9.\nCEO William Li confirmed that Nio plans on adding three new models to the Nio Technology Platform 2.0 in 2022. One of the models will be the new ET7 sedan. The other two are still unknown.\nFans of NIO stock are also waiting for an update on overseas delivery times and availability, especially in European countries. The company will likely answer this question at Nio Day.\nLi confirmed during a Q2 conference call that Nio had assembled a team to work on a new vehicle brand. In regards to the possible new vehicle brand, Li commented, “The relationship between Nio and our new mass-market brand will be like that of Audi-Volkswagen and Lexus-Toyota.”","news_type":1,"symbols_score_info":{"NIO":0.9}},"isVote":1,"tweetType":1,"viewCount":835,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":690090549,"gmtCreate":1639611551274,"gmtModify":1639611551369,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094269572113460","authorIdStr":"4094269572113460"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/690090549","repostId":"2191997591","repostType":4,"isVote":1,"tweetType":1,"viewCount":759,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":878664620,"gmtCreate":1637191026384,"gmtModify":1637191026384,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094269572113460","authorIdStr":"4094269572113460"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/878664620","repostId":"2184764854","repostType":2,"isVote":1,"tweetType":1,"viewCount":885,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":871487502,"gmtCreate":1637106173994,"gmtModify":1637106174132,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094269572113460","authorIdStr":"4094269572113460"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/871487502","repostId":"2184881094","repostType":4,"isVote":1,"tweetType":1,"viewCount":420,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":868067397,"gmtCreate":1632555000819,"gmtModify":1632657957683,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094269572113460","authorIdStr":"4094269572113460"},"themes":[],"htmlText":"Pls like&nbsp;","listText":"Pls like&nbsp;","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/868067397","repostId":"1188909032","repostType":4,"repost":{"id":"1188909032","kind":"news","pubTimestamp":1632531451,"share":"https://www.laohu8.com/m/news/1188909032?lang=zh_CN&edition=full","pubTime":"2021-09-25 08:57","market":"us","language":"en","title":"5 Top Consumer Stocks To Watch Ahead Of October 2021<blockquote>2021年10月之前值得关注的5只顶级消费股</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1188909032","media":"Nasdaq","summary":"Do You Have These Top Consumer Stocks On Your Radar Now?\nThe past trading week has been exciting, to","content":"<p>Do You Have These Top Consumer Stocks On Your Radar Now?</p><p><blockquote>您现在关注这些顶级消费股吗？</blockquote></p><p> The past trading week has been exciting, to say the least. Despite all of the ups and downs,consumer stockscontinue to make waves in thestock market today. If anything, the consumer-focused industry continues to hold strong now. This is evident as August’s retail sales figures smashed expectations, rising by 0.7% versus an estimated drop of 0.8%. Moreover, the current broad-based rebound in thestock marketcould indicate that investors’ sentiment on the economy is improving.</p><p><blockquote>至少可以说，过去的交易周令人兴奋。尽管经历了大起大落，消费类股今天继续在股市上掀起波澜。如果说有什么不同的话，那就是以消费者为中心的行业现在继续保持强劲。这一点很明显，8月份零售额数据超出预期，增长0.7%，而预期下降0.8%。此外，当前股市的广泛反弹可能表明投资者对经济的信心正在改善。</blockquote></p><p> Evidently, we could look at the likes of<b>Roku</b>(NASDAQ: ROKU) right now. Just yesterday, Guggenheim analyst Michael Morris provided a positive update on the stock. Namely, Morris hit ROKU stock with a Buy rating and a price target of $395. Morris cites Roku’s aggressive expansion of its original content and penetration of international markets as core reasons for the upgrade.</p><p><blockquote>显然，我们可以看看<b>Roku</b>（纳斯达克：ROKU）现在。就在昨天，古根海姆分析师迈克尔·莫里斯提供了该股的积极更新。也就是说，Morris给予ROKU股票买入评级，目标价为395美元。Morris将Roku对其原创内容的积极扩张和对国际市场的渗透作为升级的核心原因。</blockquote></p><p> At the same time, there is some interesting movement going on with<b>Nike’s</b>(NYSE: NKE) shares as well. Yesterday, the company posted its first-quarter earnings after the closing bell. In short, Nike reported an earnings per share of $1.16 on revenue of $12.25 billion for the quarter. This is against estimates of $1.11 and $12.46 billion. Investors appear to be focusing on Nike’s revenue miss which is mostly due to temporary supply chain pressures. Regardless, as one of the biggest names in the sports apparel industry globally, some could see opportunity in NKE stocks’ current weakness. With all this activity in the space now, could one of these consumer stocks be worth investing in?</p><p><blockquote>与此同时，有一些有趣的运动正在进行<b>耐克的</b>（纽约证券交易所代码：NKE）的股票也是如此。昨天，该公司在收盘后公布了第一季度财报。简而言之，耐克报告本季度每股收益为1.16美元，营收为122.5亿美元。相比之下，估计为11.1亿美元和124.6亿美元。投资者似乎关注耐克的营收下滑，这主要是由于暂时的供应链压力。无论如何，作为全球运动服装行业最大的品牌之一，一些人可能会从NKE股票当前的疲软中看到机会。鉴于目前该领域的所有活动，这些消费股中的一只值得投资吗？</blockquote></p><p> Best Consumer Stocks To Buy [Or Sell] Today</p><p><blockquote>今天最值得买入[或卖出]的消费股</blockquote></p><p> <ul>  <li><b>Beyond Meat Inc.</b>(NASDAQ: BYND)</li>  <li><b>Trip.com Group Ltd.</b>(NASDAQ: TCOM)</li>  <li><b>Vail Resorts Inc.</b>(NYSE: MTN)</li>  <li><b>Costco Wholesale Corporation</b>(NASDAQ: COST)</li>  <li><b>Stitch Fix Inc.</b>(NASDAQ: SFIX)</li> </ul> Beyond Meat Inc.</p><p><blockquote><ul><li><b>Beyond Meat公司。</b>（纳斯达克：BYND）</li><li><b>携程集团有限公司。</b>（纳斯达克：TCOM）</li><li><b>韦尔度假村公司。</b>（纽约证券交易所代码：MTN）</li><li><b>好市多批发公司</b>（纳斯达克：成本）</li><li><b>缝合修复公司。</b>（纳斯达克：SFIX）</li></ul>Beyond Meat公司。</blockquote></p><p> <b>Beyond Meat</b>is a plant-based meat substitutes retailer with headquarters in California. The company offers plant-based options in the beef, poultry, and pork categories. In fact, it is one of the fastest-growing food companies in the U.S. as more people are increasingly alternating to plant-based options. Its products are designed to have the same taste and texture as animal-based meat while being the better option for the environment. BYND stock has almost doubled in valuation since its pandemic era low.</p><p><blockquote><b>Beyond Meat</b>是一家植物性肉类替代品零售商，总部位于加利福尼亚州。该公司提供牛肉、家禽和猪肉类别的植物性选择。事实上，随着越来越多的人越来越多地转向植物性食品，它是美国发展最快的食品公司之一。它的产品被设计成具有与动物性肉类相同的味道和质地，同时也是更好的环境选择。自大流行时代低点以来，BYND股票的估值几乎翻了一番。</blockquote></p><p> In August, the company reported its second-quarter financials. Diving in, net revenue for the quarter was $149.4 million, increasing by 31.8% year-over-year. Furthermore, gross profit for the quarter was $47.4 million. The company saw record net revenues and also continues to return to growth in the foodservice industry as its customers welcome consumers back to their venues. Not resting on its laurels, the company also continues to make substantial investments in its long-term growth in the U.S. and abroad. Given all of this, will you consider investing in BYND stock right now?</p><p><blockquote>8月，该公司公布了第二季度财务数据。该季度净收入为1.494亿美元，同比增长31.8%。此外，该季度毛利润为4740万美元。该公司实现了创纪录的净收入，并且随着客户欢迎消费者回到他们的场所，餐饮服务行业也继续恢复增长。该公司并没有固步自封，还继续为其在美国和海外的长期增长进行大量投资。鉴于所有这些，您现在会考虑投资BYND股票吗？</blockquote></p><p> <img src=\"https://static.tigerbbs.com/875119289e70dc28e620fb5eeb2d291b\" tg-width=\"759\" tg-height=\"468\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\">Source: TD Ameritrade TOS</p><p><blockquote>资料来源：德美利证券TOS</blockquote></p><p> <b>[Read More]</b>&nbsp;What Stocks To Buy Today? 5 Tech Stocks To Watch</p><p><blockquote><b>[阅读更多]</b>今天买什么股票？5只值得关注的科技股</blockquote></p><p> Trip.com Group Ltd</p><p><blockquote>携程集团有限公司</blockquote></p><p> Following that, we have multinational online travel company<b>Trip.com</b>, a leading one-stop travel platform globally. It integrates a comprehensive suite of travel products and services and differentiated travel content. It is the go-to destination for travelers in China and around the world. Impressively, it is currently one of the largest online travel agencies in China and also one of the largest travel service providers in the world.</p><p><blockquote>接下来，我们有跨国在线旅游公司<b>Trip.com</b>，全球领先的一站式旅游平台。它整合了一套全面的旅游产品和服务以及差异化的旅游内容。它是中国和世界各地游客的首选目的地。令人印象深刻的是，它是目前中国最大的在线旅行社之一，也是全球最大的旅游服务提供商之一。</blockquote></p><p> After yesterday’s closing bell, Trip.com posted solid figures in its second fiscal quarter earnings report. In it, the company saw a total revenue of $912 million for the quarter. This marks a significant year-over-year jump of 86%. In terms of net income, the company saw a 43% increase over the same period. CEO Jane Sun cites Trip.com’s focus on the domestic market as a core contributor to this solid quarter for the company. Overall, given this piece of news, will you consider adding TCOM stock to your portfolio right now?</p><p><blockquote>昨天收盘后，携程在第二财季财报中公布了稳健的数据。该公司本季度总收入为9.12亿美元。这标志着同比大幅增长86%。净利润方面，该公司同期增长了43%。首席执行官Jane Sun表示，携程对国内市场的关注是该公司本季度业绩强劲的核心贡献者。总体而言，鉴于这条消息，您现在会考虑将TCOM股票添加到您的投资组合中吗？</blockquote></p><p> <img src=\"https://static.tigerbbs.com/781e08ea2e30a4f9c94020727b3e77bc\" tg-width=\"759\" tg-height=\"468\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\">Source: TD Ameritrade TOSVail Resorts Inc.</p><p><blockquote>资料来源：德美利证券TOSVail Resorts Inc.</blockquote></p><p> <b>Vail Resorts</b>is a leading global mountain resort operator. The company and its subsidiaries operate 37 destination mountain resorts and regional ski areas. In essence, it owns and/or manages a collection of casually elegant hotels under the RockResorts brand. It also has a development company that is in the real estate planning and development business. MTN stock is up by over 40% in the past year alone.</p><p><blockquote><b>韦尔度假村</b>是全球领先的山地度假村运营商。该公司及其子公司经营着37个目的地山地度假村和区域滑雪场。本质上，它拥有和/或管理RockResorts品牌下的一系列休闲优雅的酒店。它还拥有一家从事房地产规划和开发业务的开发公司。仅去年一年，MTN股价就上涨了40%以上。</blockquote></p><p></p><p> Recently, KeyBanc Capital Markets upgraded Vail Resorts to an Overweight rating from Sector Weight and hit it with a price target of $355. Analyst Brett Andreas says that demand for skiing vacations was exceeding expectations with some bookings already at record levels. Not to mention, the company continues to gain momentum on the financial front. In its fourth fiscal quarterearnings call, Vail reported a net income of $127.9 million, marking a sizable 29.4% year-over-year increase. After considering that pandemic-related factors still weigh on its key operations, the company’s fundamentals are admirable. Moreover, the company also declared a cash dividend of $0.88 per share, to investors’ delight. All things considered, will you buy MTN stock?</p><p><blockquote>最近，KeyBanc Capital Markets将Vail Resorts的评级从行业权重上调至跑赢大盘，并将其目标价定为355美元。分析师布雷特·安德烈亚斯表示，滑雪度假的需求超出了预期，一些预订量已经达到创纪录水平。更不用说，该公司在财务方面继续获得动力。在第四财季收益看涨期权中，韦尔公布净利润为1.279亿美元，同比大幅增长29.4%。在考虑到大流行相关因素仍然拖累其关键业务后，该公司的基本面令人钦佩。此外，该公司还宣布派发每股0.88美元的现金股息，令投资者感到高兴。综合考虑，您会购买MTN股票吗？</blockquote></p><p> <img src=\"https://static.tigerbbs.com/c596fd2c2dc3ef4d15e9c9dfa89b8147\" tg-width=\"759\" tg-height=\"468\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\">Source: TD Ameritrade TOS</p><p><blockquote>资料来源：德美利证券TOS</blockquote></p><p> <b>[Read More]</b>&nbsp;4 Semiconductor Stocks To Watch Right Now</p><p><blockquote><b>[阅读更多]</b>目前值得关注的4只半导体股票</blockquote></p><p> Costco Wholesale Corporation</p><p><blockquote>好市多批发公司</blockquote></p><p> Next up, we will be taking a look at<b>Costco</b>. For the most part, the multinational consumer staples giant would be another player to consider in thestock market today. The main factor differentiating Costco from its retail competitors would be its membership-only big-box operations. Simply put, the company only caters to members and sells daily necessities in bulk. Amidst the ongoing pandemic and climate crises, Costco’s offerings could see greater demand from consumers.</p><p><blockquote>接下来，我们将看看<b>Costco</b>在很大程度上，这家跨国消费品巨头将是当今股市中另一个值得考虑的参与者。Costco区别于零售竞争对手的主要因素是其仅限会员的大卖场业务。简单来说，公司只迎合会员，散装销售日用品。在持续的大流行和气候危机中，好市多的产品可能会受到消费者更大的需求。</blockquote></p><p> By and large, with COST stock sitting on year-to-date gains of over 19%, could it be worth investing in? Well, for one thing, the company beat Wall Streets’ projections across the board in its latest quarterly earnings report. In detail, Costco posted an earnings per share of $3.76 on revenue of $62.7 billion for the quarter. For some perspective, consensus estimates suggest an earnings per share of $3.59 on revenue of $61.6 billion. All in all, would you consider adding COST stock to your portfolio?</p><p><blockquote>总的来说，成本股今年迄今的涨幅超过19%，值得投资吗？一方面，该公司在最新的季度收益报告中全面超出了华尔街的预测。具体而言，Costco公布本季度每股收益为3.76美元，营收为627亿美元。从某种角度来看，普遍预期每股收益为3.59美元，营收为616亿美元。总而言之，您会考虑将成本股票添加到您的投资组合中吗？</blockquote></p><p> <img src=\"https://static.tigerbbs.com/0412ae414ccd0df0d5f93302bd037b56\" tg-width=\"759\" tg-height=\"468\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\">Source: TD Ameritrade TOS</p><p><blockquote>资料来源：德美利证券TOS</blockquote></p><p> <b>[Read More]</b>&nbsp;Top Stocks To Buy Now? 4 Renewable Energy Stocks For Your Watchlist</p><p><blockquote><b>[阅读更多]</b>现在最值得购买的股票？值得您关注的4只可再生能源股票</blockquote></p><p> Stitch Fix Inc.</p><p><blockquote>缝合修复公司。</blockquote></p><p> Another name to know in the consumer stock space now would be<b>Stitch Fix</b>. In brief, it is an online personal styling service. Through a combination of artificial intelligence and data science, Stitch Fix provides customers with personalized e-commerce experiences. Given the prevalence of online shopping throughout the pandemic, SFIX stock could be in focus among investors. In fact, the company’s shares are up by over 15% just this week on account of its solid earnings report.</p><p><blockquote>现在消费股领域中另一个值得了解的名字是<b>缝合固定</b>简而言之，它是一种在线个人造型服务。通过人工智能和数据科学的结合，Stitch Fix为客户提供个性化的电子商务体验。鉴于在线购物在整个大流行期间的盛行，SFIX股票可能会成为投资者关注的焦点。事实上，由于其稳健的盈利报告，该公司股价仅本周就上涨了15%以上。</blockquote></p><p> Notably, Stitch Fix raked in a total revenue of $571.16 million for the quarter, marking a 28% year-over-year increase. Additionally, the company also reported massive year-over-year spikes of over 145% in both its net income and earnings per share. Despite beating analyst estimates on these fronts, Stitch Fix does not seem to be slowing down anytime soon. This appears to be the case as the company is expanding its services with Stitch Fix Freestyle, a “differentiated shopping experience”. This would give customers a more instant and flexible means of shopping on its platform. As such, could SFIX stock be a top pick in the stock market now?</p><p><blockquote>值得注意的是，Stitch Fix本季度总收入为5.7116亿美元，同比增长28%。此外，该公司还报告称，其净利润和每股收益同比大幅增长超过145%。尽管在这些方面超出了分析师的预期，但Stitch Fix似乎不会很快放缓。这似乎是因为该公司正在通过Stitch Fix Freestyle扩展其服务，这是一种“差异化的购物体验”。这将为客户提供一种更即时、更灵活的方式在其平台上购物。因此，SFIX股票现在能成为股市的首选吗？</blockquote></p><p></p>","source":"lsy1603171495471","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Top Consumer Stocks To Watch Ahead Of October 2021<blockquote>2021年10月之前值得关注的5只顶级消费股</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Top Consumer Stocks To Watch Ahead Of October 2021<blockquote>2021年10月之前值得关注的5只顶级消费股</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Nasdaq</strong><span class=\"h-time small\">2021-09-25 08:57</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Do You Have These Top Consumer Stocks On Your Radar Now?</p><p><blockquote>您现在关注这些顶级消费股吗？</blockquote></p><p> The past trading week has been exciting, to say the least. Despite all of the ups and downs,consumer stockscontinue to make waves in thestock market today. If anything, the consumer-focused industry continues to hold strong now. This is evident as August’s retail sales figures smashed expectations, rising by 0.7% versus an estimated drop of 0.8%. Moreover, the current broad-based rebound in thestock marketcould indicate that investors’ sentiment on the economy is improving.</p><p><blockquote>至少可以说，过去的交易周令人兴奋。尽管经历了大起大落，消费类股今天继续在股市上掀起波澜。如果说有什么不同的话，那就是以消费者为中心的行业现在继续保持强劲。这一点很明显，8月份零售额数据超出预期，增长0.7%，而预期下降0.8%。此外，当前股市的广泛反弹可能表明投资者对经济的信心正在改善。</blockquote></p><p> Evidently, we could look at the likes of<b>Roku</b>(NASDAQ: ROKU) right now. Just yesterday, Guggenheim analyst Michael Morris provided a positive update on the stock. Namely, Morris hit ROKU stock with a Buy rating and a price target of $395. Morris cites Roku’s aggressive expansion of its original content and penetration of international markets as core reasons for the upgrade.</p><p><blockquote>显然，我们可以看看<b>Roku</b>（纳斯达克：ROKU）现在。就在昨天，古根海姆分析师迈克尔·莫里斯提供了该股的积极更新。也就是说，Morris给予ROKU股票买入评级，目标价为395美元。Morris将Roku对其原创内容的积极扩张和对国际市场的渗透作为升级的核心原因。</blockquote></p><p> At the same time, there is some interesting movement going on with<b>Nike’s</b>(NYSE: NKE) shares as well. Yesterday, the company posted its first-quarter earnings after the closing bell. In short, Nike reported an earnings per share of $1.16 on revenue of $12.25 billion for the quarter. This is against estimates of $1.11 and $12.46 billion. Investors appear to be focusing on Nike’s revenue miss which is mostly due to temporary supply chain pressures. Regardless, as one of the biggest names in the sports apparel industry globally, some could see opportunity in NKE stocks’ current weakness. With all this activity in the space now, could one of these consumer stocks be worth investing in?</p><p><blockquote>与此同时，有一些有趣的运动正在进行<b>耐克的</b>（纽约证券交易所代码：NKE）的股票也是如此。昨天，该公司在收盘后公布了第一季度财报。简而言之，耐克报告本季度每股收益为1.16美元，营收为122.5亿美元。相比之下，估计为11.1亿美元和124.6亿美元。投资者似乎关注耐克的营收下滑，这主要是由于暂时的供应链压力。无论如何，作为全球运动服装行业最大的品牌之一，一些人可能会从NKE股票当前的疲软中看到机会。鉴于目前该领域的所有活动，这些消费股中的一只值得投资吗？</blockquote></p><p> Best Consumer Stocks To Buy [Or Sell] Today</p><p><blockquote>今天最值得买入[或卖出]的消费股</blockquote></p><p> <ul>  <li><b>Beyond Meat Inc.</b>(NASDAQ: BYND)</li>  <li><b>Trip.com Group Ltd.</b>(NASDAQ: TCOM)</li>  <li><b>Vail Resorts Inc.</b>(NYSE: MTN)</li>  <li><b>Costco Wholesale Corporation</b>(NASDAQ: COST)</li>  <li><b>Stitch Fix Inc.</b>(NASDAQ: SFIX)</li> </ul> Beyond Meat Inc.</p><p><blockquote><ul><li><b>Beyond Meat公司。</b>（纳斯达克：BYND）</li><li><b>携程集团有限公司。</b>（纳斯达克：TCOM）</li><li><b>韦尔度假村公司。</b>（纽约证券交易所代码：MTN）</li><li><b>好市多批发公司</b>（纳斯达克：成本）</li><li><b>缝合修复公司。</b>（纳斯达克：SFIX）</li></ul>Beyond Meat公司。</blockquote></p><p> <b>Beyond Meat</b>is a plant-based meat substitutes retailer with headquarters in California. The company offers plant-based options in the beef, poultry, and pork categories. In fact, it is one of the fastest-growing food companies in the U.S. as more people are increasingly alternating to plant-based options. Its products are designed to have the same taste and texture as animal-based meat while being the better option for the environment. BYND stock has almost doubled in valuation since its pandemic era low.</p><p><blockquote><b>Beyond Meat</b>是一家植物性肉类替代品零售商，总部位于加利福尼亚州。该公司提供牛肉、家禽和猪肉类别的植物性选择。事实上，随着越来越多的人越来越多地转向植物性食品，它是美国发展最快的食品公司之一。它的产品被设计成具有与动物性肉类相同的味道和质地，同时也是更好的环境选择。自大流行时代低点以来，BYND股票的估值几乎翻了一番。</blockquote></p><p> In August, the company reported its second-quarter financials. Diving in, net revenue for the quarter was $149.4 million, increasing by 31.8% year-over-year. Furthermore, gross profit for the quarter was $47.4 million. The company saw record net revenues and also continues to return to growth in the foodservice industry as its customers welcome consumers back to their venues. Not resting on its laurels, the company also continues to make substantial investments in its long-term growth in the U.S. and abroad. Given all of this, will you consider investing in BYND stock right now?</p><p><blockquote>8月，该公司公布了第二季度财务数据。该季度净收入为1.494亿美元，同比增长31.8%。此外，该季度毛利润为4740万美元。该公司实现了创纪录的净收入，并且随着客户欢迎消费者回到他们的场所，餐饮服务行业也继续恢复增长。该公司并没有固步自封，还继续为其在美国和海外的长期增长进行大量投资。鉴于所有这些，您现在会考虑投资BYND股票吗？</blockquote></p><p> <img src=\"https://static.tigerbbs.com/875119289e70dc28e620fb5eeb2d291b\" tg-width=\"759\" tg-height=\"468\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\">Source: TD Ameritrade TOS</p><p><blockquote>资料来源：德美利证券TOS</blockquote></p><p> <b>[Read More]</b>&nbsp;What Stocks To Buy Today? 5 Tech Stocks To Watch</p><p><blockquote><b>[阅读更多]</b>今天买什么股票？5只值得关注的科技股</blockquote></p><p> Trip.com Group Ltd</p><p><blockquote>携程集团有限公司</blockquote></p><p> Following that, we have multinational online travel company<b>Trip.com</b>, a leading one-stop travel platform globally. It integrates a comprehensive suite of travel products and services and differentiated travel content. It is the go-to destination for travelers in China and around the world. Impressively, it is currently one of the largest online travel agencies in China and also one of the largest travel service providers in the world.</p><p><blockquote>接下来，我们有跨国在线旅游公司<b>Trip.com</b>，全球领先的一站式旅游平台。它整合了一套全面的旅游产品和服务以及差异化的旅游内容。它是中国和世界各地游客的首选目的地。令人印象深刻的是，它是目前中国最大的在线旅行社之一，也是全球最大的旅游服务提供商之一。</blockquote></p><p> After yesterday’s closing bell, Trip.com posted solid figures in its second fiscal quarter earnings report. In it, the company saw a total revenue of $912 million for the quarter. This marks a significant year-over-year jump of 86%. In terms of net income, the company saw a 43% increase over the same period. CEO Jane Sun cites Trip.com’s focus on the domestic market as a core contributor to this solid quarter for the company. Overall, given this piece of news, will you consider adding TCOM stock to your portfolio right now?</p><p><blockquote>昨天收盘后，携程在第二财季财报中公布了稳健的数据。该公司本季度总收入为9.12亿美元。这标志着同比大幅增长86%。净利润方面，该公司同期增长了43%。首席执行官Jane Sun表示，携程对国内市场的关注是该公司本季度业绩强劲的核心贡献者。总体而言，鉴于这条消息，您现在会考虑将TCOM股票添加到您的投资组合中吗？</blockquote></p><p> <img src=\"https://static.tigerbbs.com/781e08ea2e30a4f9c94020727b3e77bc\" tg-width=\"759\" tg-height=\"468\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\">Source: TD Ameritrade TOSVail Resorts Inc.</p><p><blockquote>资料来源：德美利证券TOSVail Resorts Inc.</blockquote></p><p> <b>Vail Resorts</b>is a leading global mountain resort operator. The company and its subsidiaries operate 37 destination mountain resorts and regional ski areas. In essence, it owns and/or manages a collection of casually elegant hotels under the RockResorts brand. It also has a development company that is in the real estate planning and development business. MTN stock is up by over 40% in the past year alone.</p><p><blockquote><b>韦尔度假村</b>是全球领先的山地度假村运营商。该公司及其子公司经营着37个目的地山地度假村和区域滑雪场。本质上，它拥有和/或管理RockResorts品牌下的一系列休闲优雅的酒店。它还拥有一家从事房地产规划和开发业务的开发公司。仅去年一年，MTN股价就上涨了40%以上。</blockquote></p><p></p><p> Recently, KeyBanc Capital Markets upgraded Vail Resorts to an Overweight rating from Sector Weight and hit it with a price target of $355. Analyst Brett Andreas says that demand for skiing vacations was exceeding expectations with some bookings already at record levels. Not to mention, the company continues to gain momentum on the financial front. In its fourth fiscal quarterearnings call, Vail reported a net income of $127.9 million, marking a sizable 29.4% year-over-year increase. After considering that pandemic-related factors still weigh on its key operations, the company’s fundamentals are admirable. Moreover, the company also declared a cash dividend of $0.88 per share, to investors’ delight. All things considered, will you buy MTN stock?</p><p><blockquote>最近，KeyBanc Capital Markets将Vail Resorts的评级从行业权重上调至跑赢大盘，并将其目标价定为355美元。分析师布雷特·安德烈亚斯表示，滑雪度假的需求超出了预期，一些预订量已经达到创纪录水平。更不用说，该公司在财务方面继续获得动力。在第四财季收益看涨期权中，韦尔公布净利润为1.279亿美元，同比大幅增长29.4%。在考虑到大流行相关因素仍然拖累其关键业务后，该公司的基本面令人钦佩。此外，该公司还宣布派发每股0.88美元的现金股息，令投资者感到高兴。综合考虑，您会购买MTN股票吗？</blockquote></p><p> <img src=\"https://static.tigerbbs.com/c596fd2c2dc3ef4d15e9c9dfa89b8147\" tg-width=\"759\" tg-height=\"468\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\">Source: TD Ameritrade TOS</p><p><blockquote>资料来源：德美利证券TOS</blockquote></p><p> <b>[Read More]</b>&nbsp;4 Semiconductor Stocks To Watch Right Now</p><p><blockquote><b>[阅读更多]</b>目前值得关注的4只半导体股票</blockquote></p><p> Costco Wholesale Corporation</p><p><blockquote>好市多批发公司</blockquote></p><p> Next up, we will be taking a look at<b>Costco</b>. For the most part, the multinational consumer staples giant would be another player to consider in thestock market today. The main factor differentiating Costco from its retail competitors would be its membership-only big-box operations. Simply put, the company only caters to members and sells daily necessities in bulk. Amidst the ongoing pandemic and climate crises, Costco’s offerings could see greater demand from consumers.</p><p><blockquote>接下来，我们将看看<b>Costco</b>在很大程度上，这家跨国消费品巨头将是当今股市中另一个值得考虑的参与者。Costco区别于零售竞争对手的主要因素是其仅限会员的大卖场业务。简单来说，公司只迎合会员，散装销售日用品。在持续的大流行和气候危机中，好市多的产品可能会受到消费者更大的需求。</blockquote></p><p> By and large, with COST stock sitting on year-to-date gains of over 19%, could it be worth investing in? Well, for one thing, the company beat Wall Streets’ projections across the board in its latest quarterly earnings report. In detail, Costco posted an earnings per share of $3.76 on revenue of $62.7 billion for the quarter. For some perspective, consensus estimates suggest an earnings per share of $3.59 on revenue of $61.6 billion. All in all, would you consider adding COST stock to your portfolio?</p><p><blockquote>总的来说，成本股今年迄今的涨幅超过19%，值得投资吗？一方面，该公司在最新的季度收益报告中全面超出了华尔街的预测。具体而言，Costco公布本季度每股收益为3.76美元，营收为627亿美元。从某种角度来看，普遍预期每股收益为3.59美元，营收为616亿美元。总而言之，您会考虑将成本股票添加到您的投资组合中吗？</blockquote></p><p> <img src=\"https://static.tigerbbs.com/0412ae414ccd0df0d5f93302bd037b56\" tg-width=\"759\" tg-height=\"468\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\">Source: TD Ameritrade TOS</p><p><blockquote>资料来源：德美利证券TOS</blockquote></p><p> <b>[Read More]</b>&nbsp;Top Stocks To Buy Now? 4 Renewable Energy Stocks For Your Watchlist</p><p><blockquote><b>[阅读更多]</b>现在最值得购买的股票？值得您关注的4只可再生能源股票</blockquote></p><p> Stitch Fix Inc.</p><p><blockquote>缝合修复公司。</blockquote></p><p> Another name to know in the consumer stock space now would be<b>Stitch Fix</b>. In brief, it is an online personal styling service. Through a combination of artificial intelligence and data science, Stitch Fix provides customers with personalized e-commerce experiences. Given the prevalence of online shopping throughout the pandemic, SFIX stock could be in focus among investors. In fact, the company’s shares are up by over 15% just this week on account of its solid earnings report.</p><p><blockquote>现在消费股领域中另一个值得了解的名字是<b>缝合固定</b>简而言之，它是一种在线个人造型服务。通过人工智能和数据科学的结合，Stitch Fix为客户提供个性化的电子商务体验。鉴于在线购物在整个大流行期间的盛行，SFIX股票可能会成为投资者关注的焦点。事实上，由于其稳健的盈利报告，该公司股价仅本周就上涨了15%以上。</blockquote></p><p> Notably, Stitch Fix raked in a total revenue of $571.16 million for the quarter, marking a 28% year-over-year increase. Additionally, the company also reported massive year-over-year spikes of over 145% in both its net income and earnings per share. Despite beating analyst estimates on these fronts, Stitch Fix does not seem to be slowing down anytime soon. This appears to be the case as the company is expanding its services with Stitch Fix Freestyle, a “differentiated shopping experience”. This would give customers a more instant and flexible means of shopping on its platform. As such, could SFIX stock be a top pick in the stock market now?</p><p><blockquote>值得注意的是，Stitch Fix本季度总收入为5.7116亿美元，同比增长28%。此外，该公司还报告称，其净利润和每股收益同比大幅增长超过145%。尽管在这些方面超出了分析师的预期，但Stitch Fix似乎不会很快放缓。这似乎是因为该公司正在通过Stitch Fix Freestyle扩展其服务，这是一种“差异化的购物体验”。这将为客户提供一种更即时、更灵活的方式在其平台上购物。因此，SFIX股票现在能成为股市的首选吗？</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.nasdaq.com/articles/5-top-consumer-stocks-to-watch-ahead-of-october-2021-2021-09-24\">Nasdaq</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SFIX":"Stitch Fix Inc.","COST":"好市多","TCOM":"携程网","NKE":"耐克","ROKU":"Roku Inc","BYND":"Beyond Meat, Inc."},"source_url":"https://www.nasdaq.com/articles/5-top-consumer-stocks-to-watch-ahead-of-october-2021-2021-09-24","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188909032","content_text":"Do You Have These Top Consumer Stocks On Your Radar Now?\nThe past trading week has been exciting, to say the least. Despite all of the ups and downs,consumer stockscontinue to make waves in thestock market today. If anything, the consumer-focused industry continues to hold strong now. This is evident as August’s retail sales figures smashed expectations, rising by 0.7% versus an estimated drop of 0.8%. Moreover, the current broad-based rebound in thestock marketcould indicate that investors’ sentiment on the economy is improving.\nEvidently, we could look at the likes ofRoku(NASDAQ: ROKU) right now. Just yesterday, Guggenheim analyst Michael Morris provided a positive update on the stock. Namely, Morris hit ROKU stock with a Buy rating and a price target of $395. Morris cites Roku’s aggressive expansion of its original content and penetration of international markets as core reasons for the upgrade.\nAt the same time, there is some interesting movement going on withNike’s(NYSE: NKE) shares as well. Yesterday, the company posted its first-quarter earnings after the closing bell. In short, Nike reported an earnings per share of $1.16 on revenue of $12.25 billion for the quarter. This is against estimates of $1.11 and $12.46 billion. Investors appear to be focusing on Nike’s revenue miss which is mostly due to temporary supply chain pressures. Regardless, as one of the biggest names in the sports apparel industry globally, some could see opportunity in NKE stocks’ current weakness. With all this activity in the space now, could one of these consumer stocks be worth investing in?\nBest Consumer Stocks To Buy [Or Sell] Today\n\nBeyond Meat Inc.(NASDAQ: BYND)\nTrip.com Group Ltd.(NASDAQ: TCOM)\nVail Resorts Inc.(NYSE: MTN)\nCostco Wholesale Corporation(NASDAQ: COST)\nStitch Fix Inc.(NASDAQ: SFIX)\n\nBeyond Meat Inc.\nBeyond Meatis a plant-based meat substitutes retailer with headquarters in California. The company offers plant-based options in the beef, poultry, and pork categories. In fact, it is one of the fastest-growing food companies in the U.S. as more people are increasingly alternating to plant-based options. Its products are designed to have the same taste and texture as animal-based meat while being the better option for the environment. BYND stock has almost doubled in valuation since its pandemic era low.\nIn August, the company reported its second-quarter financials. Diving in, net revenue for the quarter was $149.4 million, increasing by 31.8% year-over-year. Furthermore, gross profit for the quarter was $47.4 million. The company saw record net revenues and also continues to return to growth in the foodservice industry as its customers welcome consumers back to their venues. Not resting on its laurels, the company also continues to make substantial investments in its long-term growth in the U.S. and abroad. Given all of this, will you consider investing in BYND stock right now?\nSource: TD Ameritrade TOS\n[Read More] What Stocks To Buy Today? 5 Tech Stocks To Watch\nTrip.com Group Ltd\nFollowing that, we have multinational online travel companyTrip.com, a leading one-stop travel platform globally. It integrates a comprehensive suite of travel products and services and differentiated travel content. It is the go-to destination for travelers in China and around the world. Impressively, it is currently one of the largest online travel agencies in China and also one of the largest travel service providers in the world.\nAfter yesterday’s closing bell, Trip.com posted solid figures in its second fiscal quarter earnings report. In it, the company saw a total revenue of $912 million for the quarter. This marks a significant year-over-year jump of 86%. In terms of net income, the company saw a 43% increase over the same period. CEO Jane Sun cites Trip.com’s focus on the domestic market as a core contributor to this solid quarter for the company. Overall, given this piece of news, will you consider adding TCOM stock to your portfolio right now?\nSource: TD Ameritrade TOSVail Resorts Inc.\nVail Resortsis a leading global mountain resort operator. The company and its subsidiaries operate 37 destination mountain resorts and regional ski areas. In essence, it owns and/or manages a collection of casually elegant hotels under the RockResorts brand. It also has a development company that is in the real estate planning and development business. MTN stock is up by over 40% in the past year alone.\nRecently, KeyBanc Capital Markets upgraded Vail Resorts to an Overweight rating from Sector Weight and hit it with a price target of $355. Analyst Brett Andreas says that demand for skiing vacations was exceeding expectations with some bookings already at record levels. Not to mention, the company continues to gain momentum on the financial front. In its fourth fiscal quarterearnings call, Vail reported a net income of $127.9 million, marking a sizable 29.4% year-over-year increase. After considering that pandemic-related factors still weigh on its key operations, the company’s fundamentals are admirable. Moreover, the company also declared a cash dividend of $0.88 per share, to investors’ delight. All things considered, will you buy MTN stock?\nSource: TD Ameritrade TOS\n[Read More] 4 Semiconductor Stocks To Watch Right Now\nCostco Wholesale Corporation\nNext up, we will be taking a look atCostco. For the most part, the multinational consumer staples giant would be another player to consider in thestock market today. The main factor differentiating Costco from its retail competitors would be its membership-only big-box operations. Simply put, the company only caters to members and sells daily necessities in bulk. Amidst the ongoing pandemic and climate crises, Costco’s offerings could see greater demand from consumers.\nBy and large, with COST stock sitting on year-to-date gains of over 19%, could it be worth investing in? Well, for one thing, the company beat Wall Streets’ projections across the board in its latest quarterly earnings report. In detail, Costco posted an earnings per share of $3.76 on revenue of $62.7 billion for the quarter. For some perspective, consensus estimates suggest an earnings per share of $3.59 on revenue of $61.6 billion. All in all, would you consider adding COST stock to your portfolio?\nSource: TD Ameritrade TOS\n[Read More] Top Stocks To Buy Now? 4 Renewable Energy Stocks For Your Watchlist\nStitch Fix Inc.\nAnother name to know in the consumer stock space now would beStitch Fix. In brief, it is an online personal styling service. Through a combination of artificial intelligence and data science, Stitch Fix provides customers with personalized e-commerce experiences. Given the prevalence of online shopping throughout the pandemic, SFIX stock could be in focus among investors. In fact, the company’s shares are up by over 15% just this week on account of its solid earnings report.\nNotably, Stitch Fix raked in a total revenue of $571.16 million for the quarter, marking a 28% year-over-year increase. Additionally, the company also reported massive year-over-year spikes of over 145% in both its net income and earnings per share. Despite beating analyst estimates on these fronts, Stitch Fix does not seem to be slowing down anytime soon. This appears to be the case as the company is expanding its services with Stitch Fix Freestyle, a “differentiated shopping experience”. This would give customers a more instant and flexible means of shopping on its platform. As such, could SFIX stock be a top pick in the stock market now?","news_type":1,"symbols_score_info":{"ROKU":0.9,"NKE":0.9,"TCOM":0.9,"SFIX":0.9,"BYND":0.9,"COST":0.9}},"isVote":1,"tweetType":1,"viewCount":564,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696664524,"gmtCreate":1640685161869,"gmtModify":1640685637729,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094269572113460","authorIdStr":"4094269572113460"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/696664524","repostId":"1138246031","repostType":4,"repost":{"id":"1138246031","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640683578,"share":"https://www.laohu8.com/m/news/1138246031?lang=zh_CN&edition=full","pubTime":"2021-12-28 17:26","market":"us","language":"en","title":"Novavax shares dropped another 4% in premarket trading<blockquote>Novavax股价在盘前交易中又下跌4%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1138246031","media":"Tiger Newspress","summary":"Novavax shares dropped another 4% in premarket trading.The stock plunged nearly 11% yesterday.\n\nWhy ","content":"<p>Novavax shares dropped another 4% in premarket trading.The stock plunged&nbsp;nearly 11% yesterday.</p><p><blockquote>Novavax股价在盘前交易中又下跌4%。该股昨日暴跌近11%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/04a11fff9a31214bbcf7595183a5d305\" tg-width=\"843\" tg-height=\"618\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> <b>Why Novavax Stock Is Sinking</b></p><p><blockquote><b>为什么Novavax股价下跌</b></blockquote></p><p> The company didn't announce any new developments. So what's behind the big decline?</p><p><blockquote>该公司没有宣布任何新的进展。那么大跌的背后是什么呢？</blockquote></p><p> Other&nbsp;vaccine stocks&nbsp;aren't falling nearly as much. Some were even up a little. That rules out the likelihood that declining concerns about the omicron variant played a major factor behind Novavax's drop.</p><p><blockquote>其他疫苗股的跌幅也没有那么大。有些甚至涨了一点。这排除了对奥密克戎变种的担忧下降是Novavax股价下跌的主要因素的可能性。</blockquote></p><p> Instead, investors are probably growing more anxious about Novavax's planned filing for U.S. Emergency Use Authorization (EUA) of it COVID-19 vaccine NVX-CoV2373. Some investors could also be worried about the quality of Novavax's submission to the Food and Drug Administration (FDA) even if it doesn't experience another delay with the filing.</p><p><blockquote>相反，投资者可能对Novavax计划向美国申请其COVID-19疫苗NVX-CoV2373紧急使用授权(EUA)越来越焦虑。一些投资者还可能担心Novavax向美国食品和药物管理局(FDA)提交的文件的质量，即使它的提交没有再次出现延迟。</blockquote></p><p> CEO Stanley Erck's interview with Yahoo! Finance Live last Thursday likely didn't help reassure investors. When asked about when the FDA filing would be done, Erck replied, \"It's probably going to be next week, but I'm sticking with the claim that we'll be doing this by the end of this year.\"</p><p><blockquote>首席执行官斯坦利·埃尔克接受雅虎采访！上周四的财经直播可能无助于安抚投资者。当被问及何时完成FDA备案时，Erck回答说：“可能是下周，但我坚持认为我们将在今年年底前完成这项工作。”</blockquote></p><p> <b>So what</b></p><p><blockquote><b>那又怎样</b></blockquote></p><p> Yet another delay in a U.S. filing for NVX-CoV2373 wouldn't be catastrophic for Novavax as long as the company completes the submission soon in the new year. However, management's credibility would definitely take another big blow.</p><p><blockquote>只要Novavax在新年尽快完成提交，NVX-CoV2373在美国的申请再次延迟对该公司来说不会是灾难性的。然而，管理层的信誉肯定会再次受到重大打击。</blockquote></p><p> But it's premature at this point to speculate that Novavax won't complete the U.S. EUA filing this week. It's also useless to fret about the quality of the company's FDA package. Novavax recently won European Union authorization for NVX-CoV2373. That shows that the vaccine maker can successfully meet regulators' manufacturing-quality hurdles.</p><p><blockquote>但目前推测Novavax本周不会完成美国EUA备案还为时过早。担心该公司FDA包装的质量也是没有用的。Novavax最近获得了NVX-CoV2373的欧盟授权。这表明疫苗制造商能够成功满足监管机构的生产质量障碍。</blockquote></p><p> <b>Now what</b></p><p><blockquote><b>现在怎么办</b></blockquote></p><p> Investors don't like waiting, but that's exactly what they'll have to do for now with Novavax. The company could complete its EUA filing any day now. It could also pick up new authorizations in other countries where it awaits regulatory decisions.</p><p><blockquote>投资者不喜欢等待，但这正是他们目前对Novavax必须做的事情。该公司现在可以随时完成EUA备案。它还可能在等待监管决定的其他国家获得新的授权。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax shares dropped another 4% in premarket trading<blockquote>Novavax股价在盘前交易中又下跌4%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax shares dropped another 4% in premarket trading<blockquote>Novavax股价在盘前交易中又下跌4%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-28 17:26</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Novavax shares dropped another 4% in premarket trading.The stock plunged&nbsp;nearly 11% yesterday.</p><p><blockquote>Novavax股价在盘前交易中又下跌4%。该股昨日暴跌近11%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/04a11fff9a31214bbcf7595183a5d305\" tg-width=\"843\" tg-height=\"618\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> <b>Why Novavax Stock Is Sinking</b></p><p><blockquote><b>为什么Novavax股价下跌</b></blockquote></p><p> The company didn't announce any new developments. So what's behind the big decline?</p><p><blockquote>该公司没有宣布任何新的进展。那么大跌的背后是什么呢？</blockquote></p><p> Other&nbsp;vaccine stocks&nbsp;aren't falling nearly as much. Some were even up a little. That rules out the likelihood that declining concerns about the omicron variant played a major factor behind Novavax's drop.</p><p><blockquote>其他疫苗股的跌幅也没有那么大。有些甚至涨了一点。这排除了对奥密克戎变种的担忧下降是Novavax股价下跌的主要因素的可能性。</blockquote></p><p> Instead, investors are probably growing more anxious about Novavax's planned filing for U.S. Emergency Use Authorization (EUA) of it COVID-19 vaccine NVX-CoV2373. Some investors could also be worried about the quality of Novavax's submission to the Food and Drug Administration (FDA) even if it doesn't experience another delay with the filing.</p><p><blockquote>相反，投资者可能对Novavax计划向美国申请其COVID-19疫苗NVX-CoV2373紧急使用授权(EUA)越来越焦虑。一些投资者还可能担心Novavax向美国食品和药物管理局(FDA)提交的文件的质量，即使它的提交没有再次出现延迟。</blockquote></p><p> CEO Stanley Erck's interview with Yahoo! Finance Live last Thursday likely didn't help reassure investors. When asked about when the FDA filing would be done, Erck replied, \"It's probably going to be next week, but I'm sticking with the claim that we'll be doing this by the end of this year.\"</p><p><blockquote>首席执行官斯坦利·埃尔克接受雅虎采访！上周四的财经直播可能无助于安抚投资者。当被问及何时完成FDA备案时，Erck回答说：“可能是下周，但我坚持认为我们将在今年年底前完成这项工作。”</blockquote></p><p> <b>So what</b></p><p><blockquote><b>那又怎样</b></blockquote></p><p> Yet another delay in a U.S. filing for NVX-CoV2373 wouldn't be catastrophic for Novavax as long as the company completes the submission soon in the new year. However, management's credibility would definitely take another big blow.</p><p><blockquote>只要Novavax在新年尽快完成提交，NVX-CoV2373在美国的申请再次延迟对该公司来说不会是灾难性的。然而，管理层的信誉肯定会再次受到重大打击。</blockquote></p><p> But it's premature at this point to speculate that Novavax won't complete the U.S. EUA filing this week. It's also useless to fret about the quality of the company's FDA package. Novavax recently won European Union authorization for NVX-CoV2373. That shows that the vaccine maker can successfully meet regulators' manufacturing-quality hurdles.</p><p><blockquote>但目前推测Novavax本周不会完成美国EUA备案还为时过早。担心该公司FDA包装的质量也是没有用的。Novavax最近获得了NVX-CoV2373的欧盟授权。这表明疫苗制造商能够成功满足监管机构的生产质量障碍。</blockquote></p><p> <b>Now what</b></p><p><blockquote><b>现在怎么办</b></blockquote></p><p> Investors don't like waiting, but that's exactly what they'll have to do for now with Novavax. The company could complete its EUA filing any day now. It could also pick up new authorizations in other countries where it awaits regulatory decisions.</p><p><blockquote>投资者不喜欢等待，但这正是他们目前对Novavax必须做的事情。该公司现在可以随时完成EUA备案。它还可能在等待监管决定的其他国家获得新的授权。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1138246031","content_text":"Novavax shares dropped another 4% in premarket trading.The stock plunged nearly 11% yesterday.\n\nWhy Novavax Stock Is Sinking\nThe company didn't announce any new developments. So what's behind the big decline?\nOther vaccine stocks aren't falling nearly as much. Some were even up a little. That rules out the likelihood that declining concerns about the omicron variant played a major factor behind Novavax's drop.\nInstead, investors are probably growing more anxious about Novavax's planned filing for U.S. Emergency Use Authorization (EUA) of it COVID-19 vaccine NVX-CoV2373. Some investors could also be worried about the quality of Novavax's submission to the Food and Drug Administration (FDA) even if it doesn't experience another delay with the filing.\nCEO Stanley Erck's interview with Yahoo! Finance Live last Thursday likely didn't help reassure investors. When asked about when the FDA filing would be done, Erck replied, \"It's probably going to be next week, but I'm sticking with the claim that we'll be doing this by the end of this year.\"\nSo what\nYet another delay in a U.S. filing for NVX-CoV2373 wouldn't be catastrophic for Novavax as long as the company completes the submission soon in the new year. However, management's credibility would definitely take another big blow.\nBut it's premature at this point to speculate that Novavax won't complete the U.S. EUA filing this week. It's also useless to fret about the quality of the company's FDA package. Novavax recently won European Union authorization for NVX-CoV2373. That shows that the vaccine maker can successfully meet regulators' manufacturing-quality hurdles.\nNow what\nInvestors don't like waiting, but that's exactly what they'll have to do for now with Novavax. The company could complete its EUA filing any day now. It could also pick up new authorizations in other countries where it awaits regulatory decisions.","news_type":1,"symbols_score_info":{"NVAX":0.9}},"isVote":1,"tweetType":1,"viewCount":2875,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691954726,"gmtCreate":1640130161579,"gmtModify":1640130161850,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094269572113460","authorIdStr":"4094269572113460"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/691954726","repostId":"2193663561","repostType":4,"isVote":1,"tweetType":1,"viewCount":3823,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608303279,"gmtCreate":1638612247762,"gmtModify":1638612248146,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094269572113460","authorIdStr":"4094269572113460"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/608303279","repostId":"1140678193","repostType":4,"isVote":1,"tweetType":1,"viewCount":611,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698432662,"gmtCreate":1640488189966,"gmtModify":1640488190120,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094269572113460","authorIdStr":"4094269572113460"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/698432662","repostId":"2193917872","repostType":4,"isVote":1,"tweetType":1,"viewCount":3160,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698217515,"gmtCreate":1640405186348,"gmtModify":1640405186490,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094269572113460","authorIdStr":"4094269572113460"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/698217515","repostId":"2193720178","repostType":4,"isVote":1,"tweetType":1,"viewCount":3608,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698333952,"gmtCreate":1640302602178,"gmtModify":1640302602541,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094269572113460","authorIdStr":"4094269572113460"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/698333952","repostId":"2193078140","repostType":4,"isVote":1,"tweetType":1,"viewCount":2662,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}